Comparison of EIMC programmes.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\\n"}]',published:!0,mainMedia:{caption:"Highly Cited",originalUrl:"/media/original/117"}},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"8290",leadTitle:null,fullTitle:"Pharmacognosy - Medicinal Plants",title:"Pharmacognosy",subtitle:"Medicinal Plants",reviewType:"peer-reviewed",abstract:"Pharmacognosy is a term derived from the Greek words for drug (pharmakon) and knowledge (gnosis). It is a field of study within Chemistry focused on natural products isolated from different sources and their biological activities. Research on natural products began more than a hundred years ago and has continued up to now with a plethora of research groups discovering new ideas and novel active constituents. This book compiles the latest research in the field and will be of interest to scientists, researchers, and students.",isbn:"978-1-83880-611-8",printIsbn:"978-1-83880-610-1",pdfIsbn:"978-1-83880-874-7",doi:"10.5772/intechopen.78419",price:139,priceEur:155,priceUsd:179,slug:"pharmacognosy-medicinal-plants",numberOfPages:320,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"0288b7ddce8b6d3ff07a3d78db289282",bookSignature:"Shagufta Perveen and Areej Al-Taweel",publishedDate:"June 19th 2019",coverURL:"https://cdn.intechopen.com/books/images_new/8290.jpg",numberOfDownloads:32198,numberOfWosCitations:67,numberOfCrossrefCitations:56,numberOfCrossrefCitationsByBook:1,numberOfDimensionsCitations:121,numberOfDimensionsCitationsByBook:1,hasAltmetrics:1,numberOfTotalCitations:244,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"July 13th 2018",dateEndSecondStepPublish:"August 3rd 2018",dateEndThirdStepPublish:"October 2nd 2018",dateEndFourthStepPublish:"December 21st 2018",dateEndFifthStepPublish:"February 19th 2019",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"192992",title:"Prof.",name:"Shagufta",middleName:null,surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen",profilePictureURL:"https://mts.intechopen.com/storage/users/192992/images/system/192992.png",biography:"Prof. Shagufta Perveen is a Distinguish Professor in the Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Dr. Perveen has acted as the principal investigator of major research projects funded by the research unit of King Saud University. She has more than ninety original research papers in peer-reviewed journals of international repute to her credit. She is a fellow member of the Royal Society of Chemistry UK and the American Chemical Society of the United States.",institutionString:"King Saud University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"3",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"192994",title:"Dr.",name:"Areej",middleName:null,surname:"Al-Taweel",slug:"areej-al-taweel",fullName:"Areej Al-Taweel",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:"Areej Al-Taweel is a Professor at King Saud University in Saudi Arabia. She obtained her Ph.D. from the King Saud University in 2007. She is an expert in Natural Product Isolation and structure. She has published more than forty research papers and two chapters one book in different ISI listed journals.",institutionString:"King Saud University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1200",title:"Pharmacognosy",slug:"pharmacognosy"}],chapters:[{id:"66977",title:"Introductory Chapter: Pharmacognosy",doi:"10.5772/intechopen.86019",slug:"introductory-chapter-pharmacognosy",totalDownloads:1729,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Shagufta Perveen and Areej Mohammad Al-Taweel",downloadPdfUrl:"/chapter/pdf-download/66977",previewPdfUrl:"/chapter/pdf-preview/66977",authors:[{id:"192992",title:"Prof.",name:"Shagufta",surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen"}],corrections:null},{id:"65477",title:"Role of Medicinal and Aromatic Plants: Past, Present, and Future",doi:"10.5772/intechopen.82497",slug:"role-of-medicinal-and-aromatic-plants-past-present-and-future",totalDownloads:3208,totalCrossrefCites:16,totalDimensionsCites:29,hasAltmetrics:0,abstract:"Before the concept of history began, humans undoubtedly acquired life benefits by discovering medicinal and aromatic plants that were food and medicine. As our early ancestors learned to recognize and consume selected plants, civilization and personal and group health could advance. Traditional medicine would become part of every civilization with medicinal and aromatic plants widely used and applied to maintain life. Undoubtedly, the variety of available plant materials would be tasted and tested to determine whether a plant was valuable as a food or medicine. Today, a variety of available herbs and spices are used and enjoyed throughout the world and continue to promote good health. As the benefits from medicinal and aromatic plants are recognized, these plants will have a special role for humans in the future.",signatures:"Maiko Inoue, Shinichiro Hayashi and Lyle E. Craker",downloadPdfUrl:"/chapter/pdf-download/65477",previewPdfUrl:"/chapter/pdf-preview/65477",authors:[{id:"193395",title:"Ph.D.",name:"Maiko",surname:"Inoue",slug:"maiko-inoue",fullName:"Maiko Inoue"},{id:"196850",title:"BSc.",name:"Shinichiro",surname:"Hayashi",slug:"shinichiro-hayashi",fullName:"Shinichiro Hayashi"},{id:"196853",title:"Prof.",name:"Lyle",surname:"Craker",slug:"lyle-craker",fullName:"Lyle Craker"}],corrections:null},{id:"64821",title:"Medicinal Plants of the Peruvian Amazon: Bioactive Phytochemicals, Mechanisms of Action, and Biosynthetic Pathways",doi:"10.5772/intechopen.82461",slug:"medicinal-plants-of-the-peruvian-amazon-bioactive-phytochemicals-mechanisms-of-action-and-biosynthet",totalDownloads:1511,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The objective of this book chapter is to provide consolidated and updated scientific information about the medicinal plants of the Peruvian Amazon, which has a great richness of plants; many of these are used in folkloric medicine to treat several diseases. Recently, investigations have reported that these medicinal plants possess bioactive phytochemicals against several diseases such as diabetes, cancer, inflammation, infectious diseases, and several other health problems, thus corroborating some ethnopharmacological reports. The mechanism of action for selected bioactive phytochemicals was demonstrated at the molecular level as well as the metabolic pathways involved in their biosynthesis were described. Due to the large gap in scientific information revealed in this review, we formulated a series of strategies to close these scientific knowledge gaps and achieve a sustainable exploitation of medicinal plants in the Peruvian Amazon.",signatures:"Juan Carlos Castro, Joseph Dylan Maddox, Marianela Cobos, Jae Diana Paredes, Anthony Jhoao Fasabi, Gabriel Vargas-Arana, Jorge Luis Marapara, Pedro Marcelino Adrianzen, María Zadith Casuso and Segundo Levi Estela",downloadPdfUrl:"/chapter/pdf-download/64821",previewPdfUrl:"/chapter/pdf-preview/64821",authors:[{id:"212751",title:"Dr.",name:"Juan C.",surname:"Castro",slug:"juan-c.-castro",fullName:"Juan C. Castro"},{id:"212757",title:"Dr.",name:"J. Dylan",surname:"Maddox",slug:"j.-dylan-maddox",fullName:"J. Dylan Maddox"},{id:"212758",title:"Dr.",name:"Marianela",surname:"Cobos",slug:"marianela-cobos",fullName:"Marianela Cobos"},{id:"271012",title:"Dr.",name:"Gabriel",surname:"Vargas-Arana",slug:"gabriel-vargas-arana",fullName:"Gabriel Vargas-Arana"},{id:"271963",title:"MSc.",name:"Jae D.",surname:"Paredes",slug:"jae-d.-paredes",fullName:"Jae D. Paredes"},{id:"271964",title:"Dr.",name:"Jorge L.",surname:"Marapara",slug:"jorge-l.-marapara",fullName:"Jorge L. Marapara"},{id:"283391",title:"BSc.",name:"Anthony J.",surname:"Fasabi",slug:"anthony-j.-fasabi",fullName:"Anthony J. Fasabi"},{id:"283393",title:"MSc.",name:"Pedro M.",surname:"Adrianzén",slug:"pedro-m.-adrianzen",fullName:"Pedro M. Adrianzén"},{id:"283394",title:"BSc.",name:"María Z.",surname:"Casuso",slug:"maria-z.-casuso",fullName:"María Z. Casuso"},{id:"283395",title:"BSc.",name:"Segundo L.",surname:"Estela",slug:"segundo-l.-estela",fullName:"Segundo L. Estela"}],corrections:null},{id:"64667",title:"Medicinal Plants Used as Galactagogues",doi:"10.5772/intechopen.82199",slug:"medicinal-plants-used-as-galactagogues",totalDownloads:1661,totalCrossrefCites:2,totalDimensionsCites:3,hasAltmetrics:0,abstract:"The recommended diet for human infants within the first 6 months of life is breast milk. No other natural or artificial formulation has been able to match up to this gold standard. Mothers who have attempted to pursue exclusive breastfeeding can, however, attest to numerous nutritional and non-nutritional challenges mainly resulting in insufficient milk production (hypogalactia) or the absence of milk production (agalactia). There are very few and officially recommended orthodox drugs to increase lactation. The most widely used galactagogues being chlorpromazine, sulpiride, metoclopramide and domperidone are associated with very high incidences of unpleasant side effects including their extra-pyramidal effects in both mother and infant. There is therefore a need to keep searching for more acceptable galactagogues. This section reviews current literature on medicinal plants used within the local Ghanaian community to enhance lactation. Various electronic databases such as PubMed, Science Direct, SciFinder and Google Scholar as well as published books on Ghanaian medicinal plants were searched. A total of 22 plants belonging to 13 families were reviewed with regards to their medicinal values, information on lactation and toxicity.",signatures:"Emelia Oppong Bekoe, Cindy Kitcher, Nana Ama Mireku Gyima, Gladys Schwinger and Mark Frempong",downloadPdfUrl:"/chapter/pdf-download/64667",previewPdfUrl:"/chapter/pdf-preview/64667",authors:[{id:"186992",title:"Dr.",name:"Emelia Oppong",surname:"Bekoe",slug:"emelia-oppong-bekoe",fullName:"Emelia Oppong Bekoe"},{id:"280851",title:"Dr.",name:"Cindy",surname:"Kitcher",slug:"cindy-kitcher",fullName:"Cindy Kitcher"},{id:"280852",title:"Dr.",name:"Nana Ama",surname:"Mireku-Gyimah",slug:"nana-ama-mireku-gyimah",fullName:"Nana Ama Mireku-Gyimah"},{id:"280854",title:"Dr.",name:"Mark",surname:"Frimpong",slug:"mark-frimpong",fullName:"Mark Frimpong"},{id:"280855",title:"Dr.",name:"Gladys",surname:"Schwinger",slug:"gladys-schwinger",fullName:"Gladys Schwinger"}],corrections:null},{id:"64792",title:"Medicinal Plants Used by Indigenous Communities of Oaxaca, Mexico, to Treat Gastrointestinal Disorders",doi:"10.5772/intechopen.82182",slug:"medicinal-plants-used-by-indigenous-communities-of-oaxaca-mexico-to-treat-gastrointestinal-disorders",totalDownloads:1083,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:0,abstract:"The use of medicinal plants for the treatment of gastrointestinal disorders and ethnodiseases such as diarrhea, stomachache, dysentery, “empacho” (blockage), and bile is a common strategy among indigenous communities. It is estimated that approximately 34% of medicinal plants are used to treat diseases of the digestive tract. In Mexico, gastrointestinal infections caused by bacteria, parasites, or viruses represent one of the main causes of death in children in rural populations. Our objective was to document the use of medicinal plants used by the indigenous groups of Oaxaca, Mexico, for the treatment of gastrointestinal disorders, based on previous studies, experiences, and field observations in indigenous communities and supplemented with bibliographic references. In Oaxaca, there are 16 indigenous groups, the largest being the speakers of the Zapoteco, Mixteco, Mazateco, Mixe, Chinanteco, Amuzgo, Tacuate, Chatino, and Cuicateco languages. In this review of the medicinal plants used for gastrointestinal disorders, 186 species were grouped into 147 genera and 71 botanical families, among which the largest number of species belonged to Asteraceae (29), Fabaceae (15), Euphorbiaceae (9), Solanaceae (9), and Lamiaceae (9). Different pharmacological studies showed potential for preventing microbial and fungal pathogens that cause gastrointestinal disease.",signatures:"Mónica Lilian Pérez-Ochoa, José Luis Chávez-Servia, Araceli Minerva Vera-Guzmán, Elia Nora Aquino-Bolaños and José Cruz Carrillo-Rodríguez",downloadPdfUrl:"/chapter/pdf-download/64792",previewPdfUrl:"/chapter/pdf-preview/64792",authors:[{id:"177908",title:"Prof.",name:"Jose Luis",surname:"Chavez-Servia",slug:"jose-luis-chavez-servia",fullName:"Jose Luis Chavez-Servia"},{id:"178517",title:"Dr.",name:"Elia N.",surname:"Aquino-Bolaños",slug:"elia-n.-aquino-bolanos",fullName:"Elia N. Aquino-Bolaños"},{id:"178519",title:"Dr.",name:"José C.",surname:"Carrillo-Rodríguez",slug:"jose-c.-carrillo-rodriguez",fullName:"José C. Carrillo-Rodríguez"},{id:"270332",title:"MSc.",name:"Mónica Lilian",surname:"Pérez-Ochoa",slug:"monica-lilian-perez-ochoa",fullName:"Mónica Lilian Pérez-Ochoa"},{id:"270333",title:"Dr.",name:"Araceli Minerva",surname:"Vera-Guzmán",slug:"araceli-minerva-vera-guzman",fullName:"Araceli Minerva Vera-Guzmán"}],corrections:null},{id:"64529",title:"Anticancer Activity of Uncommon Medicinal Plants from the Republic of Suriname: Traditional Claims, Preclinical Findings, and Potential Clinical Applicability against Cancer",doi:"10.5772/intechopen.82280",slug:"anticancer-activity-of-uncommon-medicinal-plants-from-the-republic-of-suriname-traditional-claims-pr",totalDownloads:2298,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Despite much progress in our understanding of the essence of cancer, remarkable advances in methods for early diagnosis, the expanding array of antineoplastic drugs and treatment modalities, as well as important refinements in their use, this disease is among the leading causes of morbidity and mortality in many parts of the world. In fact, the next decade is anticipated to bring over 20 million new cases per year globally, about half of whom will die from their disease. This indicates a need for better strategies to deal with cancer. One way to go forward is to draw lessons from ancient ethnopharmacological wisdom and to evaluate the plant biodiversity for compounds with potential antineoplastic activity. This approach has already yielded many breakthrough cytotoxic drugs such as vincristine, etoposide, paclitaxel, and irinotecan. The Republic of Suriname (South America), renowned for its pristine and highly biodiverse rain forests as well as its ethnic, cultural, and ethnopharmacological diversity, could also contribute to these developments. This chapter addresses the cancer problem throughout the world and in Suriname, extensively deals with nine plants used for treating cancer in the country, and concludes with their prospects in anticancer drug discovery and development programs.",signatures:"Dennis R.A. Mans and Euridice R. Irving",downloadPdfUrl:"/chapter/pdf-download/64529",previewPdfUrl:"/chapter/pdf-preview/64529",authors:[{id:"193905",title:"Dr.",name:"Dennis",surname:"R.A. Mans",slug:"dennis-r.a.-mans",fullName:"Dennis R.A. Mans"},{id:"281592",title:"Dr.",name:"Euridice",surname:"Irving",slug:"euridice-irving",fullName:"Euridice Irving"}],corrections:null},{id:"64833",title:"Therapeutic Use of Some Romanian Medicinal Plants",doi:"10.5772/intechopen.82477",slug:"therapeutic-use-of-some-romanian-medicinal-plants",totalDownloads:1165,totalCrossrefCites:3,totalDimensionsCites:3,hasAltmetrics:1,abstract:"Romanian traditional medicine has an extremely old history. The Dacian knowledge of the curative properties of medicinal plants was documented by Herodotus, Hippocrates, Galen, and Dioscorides. It must be emphasized that modern chemical screening has confirmed the therapeutic properties of the medicinal plants used by the Dacians. More interesting is that Dacians used many of these herbs for different dishes. Practically, for Dacians, food was medicine. Recent research on some Romanian medicinal plants has highlighted their pharmacognostical importance. It is known that currently, the importance and dynamics of the research on medicinal plants in the area of drug discovery continues to increase worldwide. The main reason is not only the high efficiency of secondary metabolites in case of serious diseases (cancer, viral infections, malaria, etc.) but also the minimization of the side effects of the synthetic drugs.",signatures:"Adina-Elena Segneanu, Claudiu Cepan, Ioan Grozescu, Florentina Cziple, Sorin Olariu, Sonia Ratiu, Viorica Lazar, Sorin Marius Murariu, Silvia Maria Velciov and Teodora Daniela Marti",downloadPdfUrl:"/chapter/pdf-download/64833",previewPdfUrl:"/chapter/pdf-preview/64833",authors:[{id:"25269",title:"Dr.",name:"Adina-Elena",surname:"Segneanu",slug:"adina-elena-segneanu",fullName:"Adina-Elena Segneanu"},{id:"156334",title:"Prof.",name:"Ioan",surname:"Grozescu",slug:"ioan-grozescu",fullName:"Ioan Grozescu"},{id:"205722",title:"Dr.",name:"Silvia",surname:"Velciov",slug:"silvia-velciov",fullName:"Silvia Velciov"},{id:"205723",title:"Prof.",name:"Sorin",surname:"Olariu",slug:"sorin-olariu",fullName:"Sorin Olariu"},{id:"205724",title:"Dr.",name:"Florentina",surname:"Cziple",slug:"florentina-cziple",fullName:"Florentina Cziple"},{id:"282836",title:"MSc.",name:"Claudiu",surname:"Cepan",slug:"claudiu-cepan",fullName:"Claudiu Cepan"},{id:"282837",title:"Dr.",name:"Sonia",surname:"Ratiu",slug:"sonia-ratiu",fullName:"Sonia Ratiu"},{id:"282839",title:"Dr.",name:"Viorica",surname:"Lazar",slug:"viorica-lazar",fullName:"Viorica Lazar"},{id:"287216",title:"Dr.",name:"Teodora Daniela",surname:"Marti",slug:"teodora-daniela-marti",fullName:"Teodora Daniela Marti"}],corrections:[{id:"66684",title:"Corrigendum to: Therapeutic Use of Some Romanian Medicinal Plants",doi:null,slug:"corrigendum-to-therapeutic-use-of-some-romanian-medicinal-plants",totalDownloads:null,totalCrossrefCites:null,correctionPdfUrl:null}]},{id:"64288",title:"Medicinal Properties of Bamboos",doi:"10.5772/intechopen.82005",slug:"medicinal-properties-of-bamboos",totalDownloads:1566,totalCrossrefCites:5,totalDimensionsCites:7,hasAltmetrics:1,abstract:"Bamboos are described as one of the most important renewable, easily obtained, and valuable of all forest resources. These plants belong to the grasses’ family (Poaceae), which covers about a quarter of the world’s plant population, within the subfamily Bambusoideae. The estimated diversity of bamboos in the world is approximately 1400 species, distributed in 116 genera. Bamboo species have been used in Southeast Asia, as a base material to produce paper, furniture, boats, bicycles, textiles, musical instruments, and food, and their leaves have also been used as a wrapping material to prevent food deterioration since ancient times. These species accumulate biologically active components such as polyphenols and other secondary plant metabolites that might explain the use of bamboo leaves in Asian traditional medicine for the treatment of hypertension, arteriosclerosis, cardiovascular disease, and certain forms of cancer. Besides the usual secondary metabolites, bamboo extracts may contain biologically active peptides and polysaccharides that still need to be further studied for their activity and their synergistic with other metabolites. Most of the studies found in the literature are from Asian bamboo species, and the potential of the Southern American species is yet to be explored.",signatures:"Katarzyna B. Wróblewska, Danielle C.S. de Oliveira, Maria Tereza Grombone-Guaratini and Paulo Roberto H. Moreno",downloadPdfUrl:"/chapter/pdf-download/64288",previewPdfUrl:"/chapter/pdf-preview/64288",authors:[{id:"270231",title:"Dr.",name:"Paulo Roberto H",surname:"Moreno",slug:"paulo-roberto-h-moreno",fullName:"Paulo Roberto H Moreno"},{id:"270245",title:"Dr.",name:"Katarzyna Barbara",surname:"Wroblewska",slug:"katarzyna-barbara-wroblewska",fullName:"Katarzyna Barbara Wroblewska"},{id:"270246",title:"MSc.",name:"Danielle C. S,",surname:"Oliveira",slug:"danielle-c.-s-oliveira",fullName:"Danielle C. S, Oliveira"},{id:"270247",title:"Dr.",name:"Maria Tereza",surname:"Grombone-Guratini",slug:"maria-tereza-grombone-guratini",fullName:"Maria Tereza Grombone-Guratini"}],corrections:null},{id:"64420",title:"Medicinal Plants for Treatment of Prevalent Diseases",doi:"10.5772/intechopen.82049",slug:"medicinal-plants-for-treatment-of-prevalent-diseases",totalDownloads:4837,totalCrossrefCites:7,totalDimensionsCites:18,hasAltmetrics:1,abstract:"This chapter focuses on reviewing publications on medicinal plants used in the treatment of common diseases such as malaria, cholera, pneumonia, tuberculosis and asthma. Traditional medicine is still recognized as the preferred primary health care system in many rural communities, due to a number of reasons including affordability and effectiveness. The review concentrated on current literature on medicinal plants, highlighting on information about ethnobotany, phytochemistry and pharmacology. The search for publications on medicinal plants with scientifically proven efficacy was carried out using electronic databases such as Science Direct, Google Scholar, SciFinder and PubMed. In all, about 46 species of different families with potent biological and pharmacological activities were reviewed. All the plants reviewed exhibited potent activity confirming their various traditional uses and their ability to treat prevalent diseases.",signatures:"Susana Oteng Mintah, Tonny Asafo-Agyei, Mary-Ann Archer, Peter Atta-Adjei Junior, Daniel Boamah, Doris Kumadoh, Alfred Appiah, Augustine Ocloo, Yaw Duah Boakye and Christian Agyare",downloadPdfUrl:"/chapter/pdf-download/64420",previewPdfUrl:"/chapter/pdf-preview/64420",authors:[{id:"182058",title:"Dr.",name:"Christian",surname:"Agyare",slug:"christian-agyare",fullName:"Christian Agyare"},{id:"186987",title:"Dr.",name:"Yaw Duah",surname:"Boakye",slug:"yaw-duah-boakye",fullName:"Yaw Duah Boakye"},{id:"268666",title:"Ms.",name:"Susana",surname:"Oteng Mintah",slug:"susana-oteng-mintah",fullName:"Susana Oteng Mintah"},{id:"282286",title:"Ms.",name:"Mary-Ann",surname:"Archer",slug:"mary-ann-archer",fullName:"Mary-Ann Archer"},{id:"282288",title:"Mr.",name:"Tonny",surname:"Asafo-Agyei",slug:"tonny-asafo-agyei",fullName:"Tonny Asafo-Agyei"},{id:"282290",title:"Mr.",name:"Peter",surname:"Atta-Adjei Junior",slug:"peter-atta-adjei-junior",fullName:"Peter Atta-Adjei Junior"},{id:"282291",title:"Dr.",name:"Daniel",surname:"Boamah",slug:"daniel-boamah",fullName:"Daniel Boamah"},{id:"282293",title:"MSc.",name:"Newman",surname:"Osafo",slug:"newman-osafo",fullName:"Newman Osafo"},{id:"282294",title:"Dr.",name:"Alfred",surname:"Appiah",slug:"alfred-appiah",fullName:"Alfred Appiah"},{id:"282297",title:"Prof.",name:"Augustine",surname:"Ocloo",slug:"augustine-ocloo",fullName:"Augustine Ocloo"}],corrections:null},{id:"64726",title:"Cytotoxic and Antitumoral Activities of Compounds Isolated from Cucurbitaceae Plants",doi:"10.5772/intechopen.82213",slug:"cytotoxic-and-antitumoral-activities-of-compounds-isolated-from-cucurbitaceae-plants",totalDownloads:1286,totalCrossrefCites:1,totalDimensionsCites:5,hasAltmetrics:0,abstract:"The WHO says that annual cases of cancer will increase from 14 million in 2012 to 22 million in the next two decades. Cancer is the second cause of death in the world; in 2015, it caused 8.8 million deaths. On the other hand, it is necessary to consider that 70% of the total deaths due to this disease occur in developing countries, who have the least resources to acquire the drugs of choice for the treatment of this disease. Although there are treatments and these are effective, there are currently cases of resistance to drugs used to treat this disease, which has led to the search for new sources of drugs or compounds effective against the cancer being active; plants are the possible sources to achieve this. Cucurbitaceae is a family of plants widely distributed on the planet which has been used traditionally for the treatment of this disease and from they have been isolated different cucurbitanes. These compounds possess a wide biological activity, antidiabetic, anti-inflammatory, hepatoprotective, or cytotoxic and antitumoral effects. The aim of this review is to present 51 cucurbitacin compounds and 2 with different structures isolated from Cucurbitaceae plants with cytotoxic or antitumoral activity.",signatures:"Carlos Alberto Méndez-Cuesta, Ana Laura Esquivel Campos, David Salinas Sánchez, Cuauhtemoc Pérez González and Salud Pérez Gutiérrez",downloadPdfUrl:"/chapter/pdf-download/64726",previewPdfUrl:"/chapter/pdf-preview/64726",authors:[{id:"224593",title:"Dr.",name:"Salud",surname:"Pérez-Gutiérrez",slug:"salud-perez-gutierrez",fullName:"Salud Pérez-Gutiérrez"}],corrections:null},{id:"64699",title:"Natural Polymers as Potential Antiaging Constituents",doi:"10.5772/intechopen.80808",slug:"natural-polymers-as-potential-antiaging-constituents",totalDownloads:1192,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:"Active pharmaceutical ingredients and pharmaceutical excipients are the core of any pharmaceutical preparation. API’s are responsible for the therapeutic activity while excipients are non-pharmacological ingredients which are used in the manufacturing of pharmaceutical preparations. As we know that some polymers have thickening property, also the water based formulations are fluid in nature therefore in order to change the rheology of such formulations various polymers are used. These polymers act by increasing the viscosity of formulations. Starch, guar gum, alginates, pectin, gelatin, agar, carrageenan, cellular derivatives are the examples of natural polymer that are used to increase the viscosity of water based formulations meant for topical application. The present review deals with the use of such natural polymers as constituents of anti-aging formulations. As is well-known that aging is a natural process in which rate of production of new cells reduces while the rate of degradation of old cells increases because the normal physiology of body changes and free radicals produced by mitochondria as a byproduct and are oxygen containing highly reactive molecules. The antiaging preparations basically neutralize the effect of free radicals and protect our cell from premature degradation. On a contrary note, the already in use synthetic polymers have adverse effect on human body as well as on environment. It is well advocated in various researches that natural polymers have no or less side effects in comparison to synthetic polymers, giving them a positive lead for incorporation to various antiaging formulations. The present review gives a deep insight on the nature of polymers used over ages, there applications and incorporation into different cosmeceuticals. It also discusses the process and mechanism of aging and the phenomenon by which cell damage can be overcome. Finally, the authors have concluded with the upcoming scenario of the use of naturally derived polymers in various skin care preparations.",signatures:"Pranati Srivastava and Syed Abul Kalam",downloadPdfUrl:"/chapter/pdf-download/64699",previewPdfUrl:"/chapter/pdf-preview/64699",authors:[{id:"267695",title:"Ms.",name:"Pranati",surname:"Srivastava",slug:"pranati-srivastava",fullName:"Pranati Srivastava"},{id:"270702",title:"Mr.",name:"Syed",surname:"Abul Kalam",slug:"syed-abul-kalam",fullName:"Syed Abul Kalam"}],corrections:null},{id:"64577",title:"Pharmacology Evaluation of Bioactive Compounds that Regulate Cervical Cancer Cells",doi:"10.5772/intechopen.82258",slug:"pharmacology-evaluation-of-bioactive-compounds-that-regulate-cervical-cancer-cells",totalDownloads:1069,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Cancer has been a public health problem that has gained a lot of death. However, in spite of the advances in the diagnosis and treatment of cervical cancer, women follow the struggle versus this disease. Also, those patients suffer from limited efficacy and specificity, undesirable effects, drug resistance, and a high cost of treatments. Currently, several studies have demonstrated the efficiency of natural products, called bioactive compounds, against cervical cancer cell lines. Bioactive compounds, including polyphenols and phenolic acids or flavonoids, etc., have antioxidant and pro-oxidant properties. These compounds are efficacy and show high specificity because probably they act as anti-oxidant and pro-oxidant. The pro-oxidant activity obstructs growth factors related to different signalling pathways that trigger cancer. Although, usually this kind of compounds helps for dispatching the apoptosis in cervical cancer cell. The aim of this chapter is reviewing how bioactive compounds affect the signalling pathways.",signatures:"Mauricio Salinas-Santander, Patricia Alvarez-Ortiz, Juan Alberto-Ascacio Valdes, Raul Rodriguez-Herrera, Alejandro Zugasti-Cruz, Ricardo Rangel-Zertuche, Victor de Jesus Suarez Valencia and Antonio Morlett-Chavez",downloadPdfUrl:"/chapter/pdf-download/64577",previewPdfUrl:"/chapter/pdf-preview/64577",authors:[{id:"183439",title:"Dr.",name:"Raul",surname:"Rodriguez-Herrera",slug:"raul-rodriguez-herrera",fullName:"Raul Rodriguez-Herrera"},{id:"193767",title:"Dr.",name:"Jesus",surname:"Morlett",slug:"jesus-morlett",fullName:"Jesus Morlett"},{id:"197592",title:"Dr.",name:"Alberto",surname:"Ascacio-Valdes",slug:"alberto-ascacio-valdes",fullName:"Alberto Ascacio-Valdes"},{id:"270341",title:"Dr.",name:"Mauricio",surname:"Salinas-Santander",slug:"mauricio-salinas-santander",fullName:"Mauricio Salinas-Santander"},{id:"280655",title:"Ms.",name:"Patricia",surname:"Alvarez-Ortiz",slug:"patricia-alvarez-ortiz",fullName:"Patricia Alvarez-Ortiz"},{id:"280658",title:"Dr.",name:"Alejandro",surname:"Zugasti-Cruz",slug:"alejandro-zugasti-cruz",fullName:"Alejandro Zugasti-Cruz"},{id:"280659",title:"Dr.",name:"Ricardo",surname:"Rangel-Zertuche",slug:"ricardo-rangel-zertuche",fullName:"Ricardo Rangel-Zertuche"},{id:"280660",title:"MSc.",name:"Victor",surname:"Suarez-Valencia",slug:"victor-suarez-valencia",fullName:"Victor Suarez-Valencia"}],corrections:null},{id:"65186",title:"Pharmacognostic Study of a Plant Seed Extract",doi:"10.5772/intechopen.81860",slug:"pharmacognostic-study-of-a-plant-seed-extract",totalDownloads:1173,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Most research work on plant source for medicines end up without the researcher reaching a conclusive indication of the implicated chemical name/structure for the cure claimed. A large majority stop at just authenticating the claimed folkloric use of the crude extract of the said plant. A thorough authentication experimental process from plant identification, literature, and methodology to bioassay-guided pursuance of the active compound is carefully penned down. In addition, a vivid descriptive literature of the separation process, difficulty encountered, financial implication of the process, and joy in achievement of results is discussed in a friendly read. Furthermore, a close of the chapter with a plea to researches to endeavor to provide answers in their quest, rather than unending questions.",signatures:"Maxwell Osaronowen Egua",downloadPdfUrl:"/chapter/pdf-download/65186",previewPdfUrl:"/chapter/pdf-preview/65186",authors:[{id:"268715",title:"Dr.",name:"Maxwell",surname:"Egua",slug:"maxwell-egua",fullName:"Maxwell Egua"}],corrections:null},{id:"65128",title:"Natural Products in Drug Discovery",doi:"10.5772/intechopen.82860",slug:"natural-products-in-drug-discovery",totalDownloads:6651,totalCrossrefCites:20,totalDimensionsCites:48,hasAltmetrics:1,abstract:"Drug discovery using natural products is a challenging task for designing new leads. It describe the bioactive compounds derived from natural resources, its phytochemical analysis, characterization and pharmacological investigation. It focuses on the success of these resources in the process of finding and discovering new and effective drug compounds that can be useful for human resources. From many years, natural products have been acting as a source of therapeutic agents and have shown beneficial uses. Only natural product drug discovery plays an important role to develop the scientific evidence of these natural resources. Research in drug discovery needs to develop robust and viable lead molecules, which step forward from a screening hit to a drug candidate through structural elucidation and structure identification through GC–MS, NMR, IR, HPLC, and HPTLC. The development of new technologies has revolutionized the screening of natural products in discovering new drugs. Utilizing these technologies gives us an opportunity to perform research in screening new molecules using a software and database to establish natural products as a major source for drug discovery. It finally leads to lead structure discovery. Powerful new technologies are revolutionizing natural herbal drug discovery.",signatures:"Akshada Amit Koparde, Rajendra Chandrashekar Doijad and Chandrakant Shripal Magdum",downloadPdfUrl:"/chapter/pdf-download/65128",previewPdfUrl:"/chapter/pdf-preview/65128",authors:[{id:"268668",title:"Dr.",name:"Akshada",surname:"Koparde",slug:"akshada-koparde",fullName:"Akshada Koparde"}],corrections:null},{id:"64600",title:"Pharmacognosy: Importance and Drawbacks",doi:"10.5772/intechopen.82396",slug:"pharmacognosy-importance-and-drawbacks",totalDownloads:1770,totalCrossrefCites:1,totalDimensionsCites:3,hasAltmetrics:0,abstract:"In many nations of the world, a great number of deaths and morbidity arising from illnesses are witnessed due to lack of basic health care. Phytotherapy has continued to play a significant role in the prevention and treatment of diseases (communicable and noncommunicable). Interestingly, more than 80% of the global populations now adopt phytotherapy as a basic source of maintaining good healthy conditions, owing to the pronounced side effects, nonavailability, and expensive nature of conventional treatment options. While this review looked at the prospects and downsides of phytomedicine as it relates to the national health care system, it established the fact that although a number of medicinal plants had been resourceful (effective) against a range of diseases, with few developed into drugs based on the available phytotherapeutics, quite a large number of them are yet to scale through clinical trials to determine their safety and efficacy. It is believed that until this is done, we hope phytomedicine to be adopted or integrated into the national health care system in many countries.",signatures:"Fatai Oladunni Balogun, Anofi Omotayo Tom Ashafa, Saheed Sabiu, Abdulwakeel Ayokun-nun Ajao, Chella Palanisamy Perumal, Mutiu Idowu Kazeem and Ahmed Adebowale Adedeji",downloadPdfUrl:"/chapter/pdf-download/64600",previewPdfUrl:"/chapter/pdf-preview/64600",authors:[{id:"200124",title:"Dr.",name:"Fatai Oladunni",surname:"Balogun",slug:"fatai-oladunni-balogun",fullName:"Fatai Oladunni Balogun"},{id:"248272",title:"Dr.",name:"Abdulwakeel",surname:"Ayokun-nun Ajao",slug:"abdulwakeel-ayokun-nun-ajao",fullName:"Abdulwakeel Ayokun-nun Ajao"},{id:"267697",title:"Prof.",name:"Ahmed",surname:"Adedeji",slug:"ahmed-adedeji",fullName:"Ahmed Adedeji"},{id:"267699",title:"Dr.",name:"Mutiu Idowu",surname:"Kazeem",slug:"mutiu-idowu-kazeem",fullName:"Mutiu Idowu Kazeem"},{id:"267700",title:"Dr.",name:"Anofi",surname:"Ashafa",slug:"anofi-ashafa",fullName:"Anofi Ashafa"},{id:"267978",title:"Dr.",name:"Chella",surname:"Perumal",slug:"chella-perumal",fullName:"Chella Perumal"},{id:"300406",title:"Dr.",name:"Saheed",surname:"Sabiu",slug:"saheed-sabiu",fullName:"Saheed Sabiu"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"6530",title:"Terpenes and Terpenoids",subtitle:null,isOpenForSubmission:!1,hash:"104f235908f326361a3ab16891949b70",slug:"terpenes-and-terpenoids",bookSignature:"Shagufta Perveen and Areej Al-Taweel",coverURL:"https://cdn.intechopen.com/books/images_new/6530.jpg",editedByType:"Edited by",editors:[{id:"192992",title:"Prof.",name:"Shagufta",surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9753",title:"Terpenes and Terpenoids",subtitle:"Recent Advances",isOpenForSubmission:!1,hash:"575689df13c78bf0e6c1be40804cd010",slug:"terpenes-and-terpenoids-recent-advances",bookSignature:"Shagufta Perveen and Areej Mohammad Al-Taweel",coverURL:"https://cdn.intechopen.com/books/images_new/9753.jpg",editedByType:"Edited by",editors:[{id:"192992",title:"Prof.",name:"Shagufta",surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1444",title:"Drug Discovery",subtitle:"Research in Pharmacognosy",isOpenForSubmission:!1,hash:"8bc52e1d2e327b804916b93037881500",slug:"drug-discovery-research-in-pharmacognosy",bookSignature:"Omboon Vallisuta and Suleiman M. Olimat",coverURL:"https://cdn.intechopen.com/books/images_new/1444.jpg",editedByType:"Edited by",editors:[{id:"73943",title:"Prof.",name:"Omboon",surname:"Vallisuta",slug:"omboon-vallisuta",fullName:"Omboon Vallisuta"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6553",title:"Seaweed Biomaterials",subtitle:null,isOpenForSubmission:!1,hash:"60cbd38f47d2f3d95f9fc80bf226200e",slug:"seaweed-biomaterials",bookSignature:"Sabyasachi Maiti",coverURL:"https://cdn.intechopen.com/books/images_new/6553.jpg",editedByType:"Edited by",editors:[{id:"180971",title:"Dr.",name:"Sabyasachi",surname:"Maiti",slug:"sabyasachi-maiti",fullName:"Sabyasachi Maiti"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6828",title:"Alkaloids",subtitle:"Their Importance in Nature and Human Life",isOpenForSubmission:!1,hash:"50b0f252045663a75760f2915a330575",slug:"alkaloids-their-importance-in-nature-and-human-life",bookSignature:"Joanna Kurek",coverURL:"https://cdn.intechopen.com/books/images_new/6828.jpg",editedByType:"Edited by",editors:[{id:"214632",title:"Dr.",name:"Joanna",surname:"Kurek",slug:"joanna-kurek",fullName:"Joanna Kurek"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7855",title:"Essential Oils",subtitle:"Oils of Nature",isOpenForSubmission:!1,hash:"4cbe4fd4ef95d61934405026e1702d4c",slug:"essential-oils-oils-of-nature",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/7855.jpg",editedByType:"Edited by",editors:[{id:"54719",title:"Prof.",name:"Hany",surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"corrigendum-to-surgical-digitally-guided-planning-for-the-mini-screw-assisted-rapid-palatal-expansio",title:"Corrigendum to: Surgical Digitally Guided Planning for the Mini-Screw Assisted Rapid Palatal Expansion (MARPE) and Suture Perforation: MARPE Guide",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/79422.pdf",downloadPdfUrl:"/chapter/pdf-download/79422",previewPdfUrl:"/chapter/pdf-preview/79422",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/79422",risUrl:"/chapter/ris/79422",chapter:{id:"78828",slug:"surgical-digitally-guided-planning-for-the-mini-screw-assisted-rapid-palatal-expansion-marpe-and-sut",signatures:"Cristiane Barros André, Bruno de Paula Machado Pasqua, José Rino Neto and Fábio Dupart Nascimento",dateSubmitted:"August 27th 2021",dateReviewed:"August 31st 2021",datePrePublished:"October 2nd 2021",datePublished:null,book:{id:"10780",title:"Current Trends in Orthodontics",subtitle:null,fullTitle:"Current Trends in Orthodontics",slug:"current-trends-in-orthodontics",publishedDate:"August 17th 2022",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null}},chapter:{id:"78828",slug:"surgical-digitally-guided-planning-for-the-mini-screw-assisted-rapid-palatal-expansion-marpe-and-sut",signatures:"Cristiane Barros André, Bruno de Paula Machado Pasqua, José Rino Neto and Fábio Dupart Nascimento",dateSubmitted:"August 27th 2021",dateReviewed:"August 31st 2021",datePrePublished:"October 2nd 2021",datePublished:null,book:{id:"10780",title:"Current Trends in Orthodontics",subtitle:null,fullTitle:"Current Trends in Orthodontics",slug:"current-trends-in-orthodontics",publishedDate:"August 17th 2022",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null},book:{id:"10780",title:"Current Trends in Orthodontics",subtitle:null,fullTitle:"Current Trends in Orthodontics",slug:"current-trends-in-orthodontics",publishedDate:"August 17th 2022",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11902",leadTitle:null,title:"Lignin - Chemistry, Structure, and Application",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tThe book aims to present the chemistry of lignin molecules, their composition, and structure, strategies for chemical modification, recent progress, and studies of biopolymer lignin. Lignin is composed of alkyl-aryl ether polymers and is found in the cell walls of trees and plants. It is known as the second most naturally abundant biopolymer. The book will focus on the application of lignin in various materials, its synthesis and characterizations, and its development prospects followed by degradation methodologies. In addition to that, it will also emphasize the strategies to prepare nano- and microparticles of lignin by various means, as well as their chemical modification to obtain desired properties. It will also include the industrial aspects of lignin, lignin derivatives, their configuration, and their significant role in thermosetting, thermoplastic materials. In addition, the book welcomes contributions on the technical and economical potential of lignin in generating green bio-fuel and fine chemicals which will or can be used as an energy source for various industrial plants.
",isbn:"978-1-83968-546-0",printIsbn:"978-1-83968-545-3",pdfIsbn:"978-1-83968-861-4",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"4c3ccf3ce961d9c60aeb9774034eeb87",bookSignature:"Associate Prof. Arpit Sand and Dr. Jaya Tuteja",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11902.jpg",keywords:"Biofuel, Esters, Ethers, Adhesives, Lignin, Structural Features, Physicochemical Properties, Degradation Techniques, Biosynthesis, Biodegradation, Kraft Lignin, Qualitative Analysis",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 14th 2022",dateEndSecondStepPublish:"June 23rd 2022",dateEndThirdStepPublish:"August 22nd 2022",dateEndFourthStepPublish:"November 10th 2022",dateEndFifthStepPublish:"January 9th 2023",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 months",secondStepPassed:!0,areRegistrationsClosed:!1,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Dr. Sand, associate professor of Chemistry, was a postdoctoral fellow at Gwangju Institute of Science & Technology, Korea, and at Karolinska Institutet, Sweden. With a keen interest in polymer synthesis, Dr. Sand is an editorial board member for Polymer Synthesis Journal by Cambridge Scholars Publishing UK and Journal of Polymer Science.",coeditorOneBiosketch:'An enthusiastic, disciplined, well-organized Assistant Professor in Chemistry, Dr. Tuteja earned her Ph.D. degree in Materials Science from the Japan Advanced Institute of Science and Technology (JAIST) in 2015 for which she was awarded an “Excellent Doctorate Student". Her research includes the development and application of heterogeneous catalysts for the effective conversion of biomass to value-added products.',coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"287032",title:"Associate Prof.",name:"Arpit",middleName:null,surname:"Sand",slug:"arpit-sand",fullName:"Arpit Sand",profilePictureURL:"https://mts.intechopen.com/storage/users/287032/images/system/287032.jpg",biography:"Dr. Arpit Sand is currently an associate professor in the Department of Chemistry, Manav Rachna University, Faridabad, India. He received his BSc in Science and MSc in Chemistry from the University of Allahabad, India, in 2004 and 2006, respectively. He received his Ph.D. in Chemistry from the same university in 2010. Dr. Sand is an editorial board member for Polymer Synthesis Journal by Cambridge Scholars Publishing UK and Journal of Polymer Science. He is an academic book editor and a reviewer for international journals including Carbohydrate Polymers, International Journal of Biological Macromolecules, and Fibers and Polymers, among others.\r\nDr. Sand’s previous roles include assistant professor (guest faculty) in the Department of Chemistry, University of Allahabad; research associate at the National Physical Laboratory (NPL) New Delhi; postdoctoral fellow at Gwangju Institute of Science & Technology (GIST), Korea; postdoctoral fellow at Karolinska Institutet, Sweden; junior researcher at the Brno University of Technology, Czech Republic; and researcher at Soongsil University, South Korea.\r\nHe has more than ten years of teaching and research experience. He is also a life member of the Indian Science Congress and Green Chemistry Network center. He has made significant contributions in the modification and characterization of graft copolymers and films decorated with chalcogenide quantum dots to tune the energy bandgap for solar energy harvesting applications. His research interests include polymer synthesis using different polymerization techniques. He has authored more than twenty-four international research articles and review articles in reputed SCI journals.",institutionString:"Manav Rachna University Faridabad",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:null}],coeditorOne:{id:"453331",title:"Dr.",name:"Jaya",middleName:null,surname:"Tuteja",slug:"jaya-tuteja",fullName:"Jaya Tuteja",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003NAhktQAD/Profile_Picture_1643970806232",biography:"Dr. Jaya Tuteja is currently working as Assistant Professor, Department of Chemistry, Faculty of Applied Science, Manav Rachna University since January 2018. She earned her Ph.D. degree in Materials Science from Japan Advanced Institute of Science and Technology (JAIST), Japan in 2015 and was awarded as “Excellent Doctorate Student” by JAIST. \r\nShe has published 5 research papers in reputed international journals with a sum of impact factor of >25. She also has 2 patents filed on her name from her Ph.D. research work. One of the articles in ChemSusChem 7 (1), 96-100 has reached a citation of more than 100 and was selected among 25 Most Accessed Articles from ChemSusChem. Her first research article was awarded a BCSJ award article. She also has 1 book chapter in her account.\r\nBefore joining Manav Rachna University, she was working in a chromatography Industry YMC India Ltd. as a Technical and Application Manager. Her research area includes the development, characterization, and application of heterogeneous catalysts for effective conversion of biomass to value-added products, nanoparticles synthesis and nanoparticle-based heterogeneous catalysts, bimetallic nanoparticles, carbohydrate chemistry, and analytical techniques for compound identification.",institutionString:"Manav Rachna University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"8",title:"Chemistry",slug:"chemistry"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"444315",firstName:"Karla",lastName:"Skuliber",middleName:null,title:"Mrs.",imageUrl:"https://mts.intechopen.com/storage/users/444315/images/20013_n.jpg",email:"karla@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"10776",title:"Cellulose Science and Derivatives",subtitle:null,isOpenForSubmission:!1,hash:"947660259ce1915c3cac58bf7d990424",slug:"cellulose-science-and-derivatives",bookSignature:"Arpit Sand and Sangita Banga",coverURL:"https://cdn.intechopen.com/books/images_new/10776.jpg",editedByType:"Edited by",editors:[{id:"287032",title:"Associate Prof.",name:"Arpit",surname:"Sand",slug:"arpit-sand",fullName:"Arpit Sand"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"872",title:"Organic Pollutants Ten Years After the Stockholm Convention",subtitle:"Environmental and Analytical Update",isOpenForSubmission:!1,hash:"f01dc7077e1d23f3d8f5454985cafa0a",slug:"organic-pollutants-ten-years-after-the-stockholm-convention-environmental-and-analytical-update",bookSignature:"Tomasz Puzyn and Aleksandra Mostrag-Szlichtyng",coverURL:"https://cdn.intechopen.com/books/images_new/872.jpg",editedByType:"Edited by",editors:[{id:"84887",title:"Dr.",name:"Tomasz",surname:"Puzyn",slug:"tomasz-puzyn",fullName:"Tomasz Puzyn"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"70312",title:"Scaling Safe Circumcisions in Communities",doi:"10.5772/intechopen.89437",slug:"scaling-safe-circumcisions-in-communities",body:'Amidst the debate on whether the benefits of circumcision outweigh risks, regardless of the reason for circumcision and irrespective of geographical, ethical and socio-economic boundaries, circumcision continues to be one of the commonest surgical procedures performed globally [1]. Since male circumcision (MC) is universal in Muslim and Jewish populations, circumcision prevalence of 99.9% was estimated, and in non-Muslim, non-Jewish states, a minimum prevalence of 0.1% was assumed to calculate the global MC prevalence of 37–39% [2]. This estimate is higher than the one given by the WHO in 2008 which was 30% [3]. The reason for the rise in MC prevalence could be attributed to the rising number of Muslims worldwide [4, 5] and to the initiation of voluntary medical male circumcision (VMMC) programmes encouraged by the WHO and the joint United Nations agency programme on HIV/AIDS—UNAIDS in sub-Saharan African countries as a preventative strategy to curb the rising incidence of HIV [2].
According to the
An estimated 23.2% of the world’s population comprise Muslims with nearly 69% of them residing in Asia and 27% in Africa [4]; 0.2% are Jews, 80% of whom live either in Israel or the USA; religious traditions in both communities staunchly advocate circumcision.
Taking Pakistan as an example of a developing Muslim country in Asia, an estimated 2.5 million male babies are born in Pakistan every year [6], almost all of whom undergo circumcision in their infancy or childhood [3]. Presently, the vast majority of circumcisions are performed by traditional circumcisers, barbers and untrained paramedical staff using unsterilized instruments and unsafe techniques with no follow-up or record of any complications; only 5–10% of boys present to qualified surgeons and physicians [7]. It would be unreasonable to rely on specialists and general practitioners to fulfill this huge unmet need for safe circumcisions, given that the estimated physician density in Pakistan is 0.978 per 1000 with only about 200 registered pediatric surgeons in the country [8]. In countries where healthcare resources are insufficient, emphasis needs to shift towards developing a public health strategy whereby appropriate non-medical personnel are trained to perform circumcisions safely, using correct technique and modern infection control practices [9].
For thousands of years, traditional circumcision has been practiced in African tribes of sub-Saharan region and amongst many ethnic groups around the world, including aboriginal Australasians, the Aztecs and Mayans in the Americas and in the Philippines [3]. The prime reason for circumcision in most of these groups is to emphasize and celebrate the occasion of rite of passage to manhood.
Around 80 percent of American men are circumcised, one of the highest rates in the developed world [10]. The USA is the only country in the world where newborn circumcision in male babies is highly prevalent, allegedly for health benefits [11], and an overwhelming majority gets circumcised in hospitals, soon after birth [12]. According to estimates, 80–95% of male infants were being circumcised in the USA by the 1970s [13]. The US Centers for Disease Control and Prevention (CDC) proclaimed that this trend showed a decline thereafter, possibly influenced by the pronouncements of the American Academy of Pediatrics (AAP) in 1971, deeming there are no valid medical indications for circumcision in the neonatal period [14]. The CDC, however, collects voluntary data only from participating hospitals, some of which withdrew neonatal circumcision services due to financial reasons, thereby displaying sharp decline in circumcision rates in those particular settings [11, 13]. Many hospitals chose to discontinue coding circumcisions as procedures which may have led to inaccuracy in the collected data; moreover, circumcisions performed during subsequent hospital admissions or as outpatients were not recorded. Therefore, accurate conclusions about the actual number of procedures being performed cannot be drawn. Nelson et al. reported that the incidence of newborn circumcision increased steadily between 1988 and 2000 in the USA from 48.3 to 61.1%, with the overall weighted incidence of circumcision being 54.4% [12]. Revision in the stance of AAP Task Force on Circumcision in 1989 to a more neutral position that stated ‘Circumcision has potential medical benefits and advantages as well as disadvantages and risks’ and that parental decisions should be based on informed consent, could be a possible factor influencing the circumcision rates. Availability of health insurance is another important factor favorably influencing the numbers of circumcisions [15]. Being the commonest surgical procedure performed in the USA, circumcision exerts a considerable impact on the health system of the country; on one hand, it usurps the medical budget by utilizing the health personnel and consumables that collectively build towards the direct cost of the procedure and its associated complications, and on the other hand, it helps to reduce any potential indirect costs by diseases that are averted as a result of benefits from the procedure.
In recent years, increasing evidence has linked male circumcision to lower rates of asymptomatic urinary tract infection (UTI) [16, 17], especially during infancy and to lower risk of transmission of sexually transmitted diseases, most notably of the HIV [18]. At the end of 2006, an estimated 39.5 million people were living with HIV, and the incidence of new cases was 4.3 million that year [19]. Three randomized controlled trials were conducted to assess the impact of MC on HIV risk [20, 21, 22]; all three studies were aborted when interim analysis showed compelling evidence that MC reduces the risk of acquiring HIV through heterosexual sex by 51–60%. This led to global attention on this procedure, thereby encouraging prophylactic circumcision in many countries with a high prevalence of HIV/AIDS [23], especially in sub-Saharan Africa. The WHO/UNAIDS recommended rapid scale-up of MC in settings where prevalence of heterosexually transmitted HIV infection is high, the levels of male circumcision are low, and populations at risk of HIV are large.
Africa has a unique burden of circumcision with many Muslim-majority countries, a high prevalence of HIV in many countries and cultural preferences in certain tribes. Somalia, a sub-Saharan African Muslim country displaying a very high birth rate and inadequate health services, has an unimpressive physician density of 0.02 per 1000. Uganda has 13.7% Muslims, with a high birth rate, physician density of 0.09 per 1000 coupled with a high burden of HIV cases. Kenya, accommodating 11.2% Muslims, with a high birth rate superimposed with a huge burden of HIV cases and a physician density of 0.2 per 1000 shows 84% of all Kenyan men are circumcised, predominantly due to cultural obligation [3].
Circumcisions prompted by religious, cultural or general health benefits are not an emergency. However, those required to control the spread of HIV epidemic globally are urgent, and crucial steps need to be taken to ensure their instatement. Therefore, the implementation of ‘voluntary medical male circumcision’ and ‘early infant male circumcision’ (EIMC) programmes to tackle HIV spread and high volumes of routine circumcisions, respectively, provide plausible solutions.
First and foremost, factual information should be clearly provided to high-risk communities in general and to the men opting for circumcision and their partners in particular. MC has shown to reduce,
The vast majority of people living with HIV belong to low- and middle-income countries, particularly in Africa. Immediate intervention proposed by the WHO/UNAIDS in 2007 for impeding HIV spread was provision and rapid scale-up of VMMC services in at least 14 vulnerable countries in Africa where HIV prevalence was high, spread was predominantly through heterosexual transmission, and MC levels were low [24]. Target was to achieve 20 million circumcisions in HIV-negative men by 2016. By the end of 2013, only 30% of the target was achieved, and a joint strategic action framework was devised by UNAIDS, the WHO and other stakeholders to review the steps in order to expedite the scale-up of VMMC to fulfill the desired goal [25]. Although the time-bound ultimate target seemed ambitious to be achieved by 2016 mainly due to large numbers of trained healthcare workers required along with a continuous flow of funds [24], all involved countries showed an increase in the pace of scale-up of VMMC programmes leading to 12 million circumcisions of adolescent boys and men by the end of 2015 [26]. This proximity to the target encouraged UNAIDS and the WHO to launch a new, more holistic framework for action—VMMC2021. This document gives newer strategic directions on VMMC for HIV prevention and envisions that 90% of males aged 10–29 years will have been circumcised by 2021, in priority settings in sub-Saharan Africa.
It should be kept in mind that VMMC is unlikely to provide public benefit in areas where HIV prevalence is low or is concentrated in specific populations such as intravenous drug users, MSM or sex workers.
Whereas VMMC programmes have been popularly introduced and implemented in high-risk populations, there is a comparative absence of EIMC programmes in relevant countries. To promote the safe circumcision initiative, a manual was developed by joint efforts of the WHO and JHPIEGO in 2010, which also provided the technical guidance for structuring an EIMC [27]. However, large-scale adoption of this recommendation by stakeholders is yet to be seen. For effective implementation, a careful needs assessment should be conducted in advance to investigate the expected scale of requirement.
Promotion of early infant male circumcision programmes could be a simple, safe, reasonable and economical strategy in countries where burden of circumcision is high, financial constraints are present, and standard of healthcare services is low. In Muslim-majority countries like Pakistan, male circumcision is considered an essential religious practice; there is unanimous consensus that the male baby should be circumcised. Therefore, the focus needs to be on ensuring that these circumcisions are performed safely, as early as possible in life with the lowest possible risk of complications. Introduction of service delivery programmes, promoting and delivering safe, sterile early infant circumcisions at a subsidized cost or as part of the free public sector healthcare package, could provide a meaningful and long-term solution.
The WHO/UNAIDS and UNICEF also recommend EIMC be implemented simultaneously with scale-up of MC services as a long-term strategy for the control of HIV. Modeling studies show promising results for universal MC in sub-Saharan Africa, claiming it could significantly reduce morbidity and mortality associated with HIV over time [19]. For effective execution of EIMC services, maternal and infant health programmes need to be engaged as well.
In countries like the USA with a high prevalence of circumcision or in other developed countries like the UK with pockets of Muslim-majority communities, the need for these procedures is high. Since medical insurance does not cover circumcision, there is risk of this procedure being restricted to affluent or insured patients, as indicated by falling circumcision rates in the USA in patients without insurance coverage [12, 15]. EIMC programmes introduced in these settings could fulfill the patient requirements as well as bring about significant cost reduction associated with the procedure.
The key aspects for successful implementation and scale-up of EIMC include training of health workers, developing programme infrastructure, ensuring supply of equipment and consumables, identifying funding and establishing robust monitoring and evaluation systems and policy development.
Health providers need to be provided with theoretical knowledge about basic anatomy of the area and details of the surgical technique [1, 27, 28] and possible complications related to the procedure. This should be followed by practical demonstration of the technique. A US-based training programme employed the Gomco clamp method of circumcision [13] to train certified nurse-midwives (CNMs) in 1981, under supervision of obstetricians. In 1996, volunteer nurses in the UK were trained by consultant urologists to perform Plastibell circumcisions. A similar protocol is being followed by an EIMC programme established in Karachi, Pakistan, since 2016, in which pediatric surgeons are training OR technicians, midwives, health workers and family physicians to perform circumcisions using the Plastibell method.
These training programmes have adopted a similar approach with theoretical training followed by skills teaching, initially performing procedures under close supervision, and subsequently independently with routine monitoring of outcomes. At the end of the training period, a knowledge and skills assessment is carried out before the health providers are certified to practice. This process allows the procedure to be performed safely and efficiently in settings where large numbers of circumcisions are required.
Task sharing is a well-established approach worldwide, whereby health providers are trained to perform high volume, technically less demanding tasks, under close supervision and monitoring with a referral system in place [29]. The ‘manual for early infant male circumcision under local anaesthesia’ by the WHO recommends that early infant male circumcision should primarily be the task of nonphysician healthcare workers which include, but are not limited to, nurses, midwives, clinical officers, health officers and assistant medical officers. Non-specialist medical doctors can also be trained for this procedure. The competence of the providers is the single most important factor affecting the outcome of the procedure and, hence, is critical to the success of any large-scale implementation.
Non-medical, religious providers called ‘mohels’, trained and supervised by the Ministry of Religion and the Ministry of Health, perform circumcisions in Israel [9]. Trained and certified nurses and midwives are another pool of non-medically trained providers that commonly perform this procedure in West Africa. Medically trained providers include obstetricians, pediatricians, general practitioners, general surgeons or pediatric surgeons and urologists, who routinely undertake ritual neonatal circumcisions in hospital settings commonly in countries like the USA and the Gulf states, in addition to performing therapeutic circumcisions in countries around the world.
The selection of the provider is influenced by preference of the family, the cost of the procedure, location, accessibility, culture and socio-economic status of the parents. If adequate numbers of physicians and specialists are available to run an EIMC, this may be the preferred approach in resource-rich settings. The real challenge arises in resource-constrained settings, especially in rural areas, where families approach traditional, untrained providers since they are the only viable option due to convenience, proximity or cost dynamics [9]. In Pakistan, 90–95% of circumcisions are performed by untrained barbers, technicians, religious or traditional circumcisers [7], who remain oblivious to the associated risks and are unable to handle complications that occur far too frequently. Similarly, barbers or traditional circumcisers are the popular choice in Egypt, Turkey and Iran for this procedure [9]. Not surprisingly, these untrained and unmonitored providers pose the biggest threat, with short- and long-term sequelae being the norm.
Links between the formal and informal health sectors could help increase the safety and quality of the procedure and enhance the monitoring and evaluation aspect of the program. In Accra (the capital of Ghana), where neonatal circumcision is almost universal, good links have been established between the Public Health Service and traditional circumcisers in order to provide regular training in safe infant circumcision. Similar models should be explored in other settings.
Circumcision is a simple surgical procedure that can be safely performed by a trained person. It does not have to be done by a doctor or a specialist. All types of health providers, whether they are surgeons, nurses, technicians or traditional circumcisers [7, 27, 28, 30], have shown comparable results as long as they are adequately trained.
The three common methods of neonatal or early infant circumcision include Plastibell, Mogen clamp and Gomco clamp. Providers can be trained to perform any of these techniques as all of them have comparable safety profiles [27, 31]. Adoption of a single method is recommended to ensure standardization of technique in order to facilitate the training of the providers and their monitoring by making fair comparisons based on occurrence of complications; additionally, employment of a single method enables ease of procurement for the program. Plastibell technique of circumcision is a simple method that is easily taught and can be performed safely by health providers with low complication rates [31, 32, 33, 34]. However, the clamping devices may be safer for EIMC in regions where follow-up services to deal with complications, like retained rings, are unavailable [33].
EIMC programmes best serve their purpose and provide maximum benefit to communities when they are integrated into existing healthcare systems such as the maternal, neonatal and child health (MNCH) programmes. For example, introduction of such programmes at birthing or vaccination centres is advised, where a stream of age-appropriate patients is already expected. Targeting these places would result in early and successful establishment of these programmes. Vertical, solitary programmes may be useful as short-term, pilot programmes or as training centres for health providers in areas where circumcision rates are high and healthcare systems are weak. Once piloted, replication and scale-up strategies should be employed to achieve sustainability.
Circumcision can be performed at any age. Judaism proposes the eighth day of life in a healthy baby; in Islam, the time could be anywhere between birth and puberty. In some Muslim countries like Pakistan, cultural pressures influence the timing of circumcision. The ritual is ordained to be celebrated as a festive occasion with special arrangements including dinner, requiring the presence of relatives and friends, especially amongst certain ethnic groups. This exerts an unnecessary financial strain on the families who often delay the circumcision of their babies till they have enough money to organize the event, which often makes them cross the beneficial age-limit of 2 months following birth. In order to discourage this practice and to create awareness amongst masses regarding the advantages of early infant circumcision, a video was developed in the national language as a tool for information dissemination by an EIMC programme established in Karachi, Pakistan. The link to this Video 1 (with English subtitles) is available here: https://bit.ly/38be8P5.
From the medical point of view, the neonatal period offers the best opportunity for circumcision with avoidance of general anesthesia and its associated challenges; additionally, it provides all possible benefits of circumcision to the baby as early as possible in life, with better and early chances of recovery, lower cost and a lower incidence of post-procedure complications. MC should not be performed until at least 24 hours after birth to ensure the infant is stable and has had time to void, feeding has initiated, and abnormalities, if any, become apparent [27]. Therefore, for large-scale EIMC programmes, early procedures performed from the second day of birth up to 2 months, in otherwise healthy babies, are preferred [27, 35]. Since circumcision is an elective procedure, it should be deferred in case the baby is unwell, underweight, preterm or if any doubts surface during screening. Physiological jaundice is not considered a contraindication; however, if the baby is deeply jaundiced, circumcision should be deferred, and referral for appropriate work up and management should be initiated as soon as possible [35, 36]. Ethical arguments propose that circumcision should be deferred till the patient is old enough to make his own decision; however, delaying or postponing the procedure negates the protective effect of circumcision required as early in life as possible and the concomitant reduced-cost benefit due to avoidance of general anesthesia.
During the 1970s in the USA when circumcision rates were at their peak, the procedure was considered so beneficial that many hospitals did not require a written consent [13]. However, in 2012, the Task Force on Circumcision (which included members of the American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP), American College of Obstetricians and Gynecologists (ACOG) and Centers for Disease Control and Prevention) stated that ‘benefits of circumcision outweigh its risks’ and strong recommendations were made to obtain ‘informed consent’ from parents or guardians prior to the procedure [1].
While establishing neonatal male circumcision programmes, the Task Force on Circumcision and the WHO [27] also recommend vitamin K to be routinely administered to the babies before the procedure in order to help prevent post-procedure bleeding. Routine pre-procedure investigations are not advocated nor justified in large-scale EIMC programmes [35]. Circumcision is contraindicated in babies born with genital abnormalities (like epispadias, hypospadias, chordee, ambiguous genitalia, micropenis, buried penis, penoscrotal web or bilateral hydrocele), blood dyscrasias or those with a family history of bleeding disorders.
Additionally, pain relief should be provided to the infant during the procedure. For this purpose, dorsal penile nerve block or ring block could be employed; the former has the advantages of lesser number of pricks and a shorter duration of onset.
If trained providers perform the procedure, post-circumcision complications are generally minor and easily managed. However, they can and do occur, even in the best hands. Health providers should be equipped to handle simple post-procedure complications like minor bleeding requiring application of pressure with or without topical adrenaline or simple cutting and removal of a Plastibell ring that fails to shed spontaneously. If these complications occur in post-clinic hours, then a referral system to handle these or other common complications following circumcision ensures the success of EIMC programmes. The ongoing recruitment and training of health providers in large-scale programmes poses a constant challenge in terms of high chances of occurrence of complications by new trainees; this can be addressed by a reliable referral system to handle these when the need arises.
Patient follow-up and outcome determination are of utmost importance in any public health intervention. In EIMC programmes, active and passive follow-up after the procedure allows documentation of post-procedure adverse events and helps assess parental satisfaction with the process. Diligent and regular review of data allows the programme team to monitor quality and safety outcomes and address any challenges that may be identified. Refresher training and modification of technique or approach may be instituted to address any issues that may arise. A helpline or open access to the clinic allows patients to call or come in with concerns that can either be adequately dealt with by the primary team or referred appropriately.
Low literacy levels, socio-economic constraints and geographical barriers are all hurdles to early recognition and reporting of complications, which if left unattended, could lead to serious adverse events following a simple procedure like neonatal circumcision [37]. Regular engagement between providers delivering health services and families in the communities, to counsel them before and after the procedure, helps build a rapport which is the basis of successful public health programmes. This bond could be utilized by the providers to probe and carry out a qualitative analysis to judge the acceptability of the programme by the community or to find ways to improve the services by getting direct input from the biggest stakeholders in this arrangement. On the other hand, the health providers could be the source of correct information and guidance for these communities regarding various aspects of health promotion. Participants of the programme usually share their experiences with others in the community; reputation, good or bad, spreads through word of mouth, either encouraging or discouraging others to opt for similar services.
Timely procurement of programme equipment like circumcision sets and boards, amongst others, along with adequate stock of consumables, is vital to ensure smooth running of these programmes. The major hurdle towards scale-up of this programme into the community and especially in rural areas is the limitation of availability of central sterile services department (CSSD) for sterilization of instruments used for circumcision. Scale-up of such programmes would be facilitated by the employment of pre-packed circumcision sets, containing single-use, low-cost instruments and consumables. This approach has already been adopted by VMMC programmes [24] in Africa but is currently under consideration and trial for EIMC programmes. Large-scale implementation would allow the cost of these sets to be minimized.
Countries which require establishment of EIMC programmes should draft a budget and allocate funds accordingly. Continuity of disbursement of funds is vital for programme operations. In countries where religious circumcision is needed and those with a high requirement of circumcision due to HIV prevalence, EIMC service delivery programmes should be established with no cost or lowest possible cost to the patient. Private donors and governments should consider cost saved from avoidance of occurrence of diseases like UTI and sexually transmitted diseases like HIV. Additionally, circumcisions performed on older children are costlier because of the need of general anesthesia and hospitalization; there is also an increased risk of post-circumcision complications in older children which require medical attention and, hence, account for added expense. Lastly, the societal cost of botched circumcisions in the hands of untrained providers must be avoided under any circumstances.
Strong coordination between the programme team members is important for effective functioning of the program. Adherence to programme guidelines, regular surveillance of data and management of inventory should be ensured by the programme manager. In our experience, the use of a software application for data collection allows real-time monitoring and rapid access to data for analysis which forms a critical part of a large-scale-up implementation. This also serves as an effective monitoring tool. All complications per provider should be recorded and feedback shared with the team on a regular basis to review and revise the technique as required.
Goals and objectives of the programme should be specified when the programme is being conceptualized. Goals are achieved over for a long term (5–10 years); as an example, with effective establishment of EIMC programmes, an increased prevalence of circumcision in infants should be detected. Objectives are shown by results achieved. Additionally, parameters to study the structure, process and outcome indicators should be delineated. These should be monitored routinely to assess the progress of the program. An example of an outcome indicator is the number of post-procedure complications out of the total procedures performed.
For scale-up of EIMC programmes, it is essential that there is a legal framework supported by policies to ensure that neonatal or early infant circumcisions are performed safely. This includes obtaining informed consent from parents or guardians prior to the procedure and, in the absence of any coercive influence, use of safe technique and sterile instruments along with reliability of trained providers. Most countries display a lacking in it but Israel is an exception [9]. According to Israeli law, circumcision of baby boys up to 6 months of age is considered a religious ritual which can be performed by religious or traditional circumcisers; beyond this age, only qualified surgeons are allowed to do so. Additionally, Israeli government is directly involved in the training of traditional providers or mohels. Formulation of a national policy on similar lines, to promote safe circumcisions in Muslim-majority countries or regions, is urgently required.
Circumcisions are being done by nurses and other health providers in VMMC programmes; however, some countries like Pakistan have not looked at task sharing as a way to address the critical shortage of healthcare professionals. A national health policy framework should be developed to facilitate and encourage task sharing [29]. This has been done successfully in maternal and child health by training nonphysician clinicians (NPCs) and traditional birth attendants (TBAs) in comprehensive emergency obstetric care [38].
While circumcision is being employed as an option to curtail the number of HIV cases, it could well be the source of spread of blood-borne infections like hepatitis or HIV, if aseptic measures are not adopted [35, 39]. Circumcisions performed by untrained traditional providers in non-clinical settings with unsterilized instruments pose the greatest threat. Therefore, awareness and training of health providers to practice a safe, sterile technique in EIMC programmes is imperative for success and scale-up. Policies should be structured to ensure sterility of equipment used for circumcision.
Table 1 shows a comparison of a few EIMC programmes of somewhat similar characteristics.
USA/ [13] | 1981–1991/10 years | 1000 | Newborns | Certified nurse-midwives | 3 | Gomco clamp | 0.1% |
UK/ [40] | 1996–1998/2 years | 168 | 6–14 weeks | Nurses | 3 | Plastibell method | 18% |
UK/ [28] | 1996–2005/9 years | 1129 | 6–14 weeks | Nurses | Not specified | Plastibell method | 8.2% |
Pakistan | From 2016 (ongoing) | 3755 | Up to 3 months | OR technicians, midwives, health workers, family med residents | 12 | Plastibell method | 3% |
Comparison of EIMC programmes.
Impact of EIMC programmes can be realized immediately in countries where religious obligation is the motivation; however, impact on HIV incidence will not be evident until at least 20 years from commencement of the programmes. Implementation followed by scale-up of EIMC programmes should be encouraged as this relieves the stress on the health system of any country requiring high volumes of circumcisions. Technicians, nurses, midwives and health workers could serve as the promising pool of task-sharers to reduce the financial and technical burden without compromising on patient safety and outcomes.
Success of these programmes depends on proper training of health providers, close monitoring of outcomes and a reliable referral system. Additionally, strict adherence to programme protocols and provision of clear instructions to families on the need for early reporting of complications are essential for best results.
The authors declare no conflict of interest.
The Chiropractic BioPhysics® (CBP®) technique was invented in 1980 by Donald D. Harrison, a chiropractor who was also educated in engineering and mathematics [1]. After reading the 1974 paper by Panjabi [2] on the recommendation for the use of a Cartesian coordinate system to accurately describe the movement of body joints as rotations and translations around an origin, he applied this concept to upright human posture (Figures 1 and 2) [1, 3]. Instead of being applied to a single joint, Harrison presented the displacement of the head, thorax and pelvis as rotations and translations of the main masses of the body, with spinal coupling patterns that occur within the corresponding spinal junctions between the adjacent body masses for each particular movement/position.
Human posture described as rotations of the head, thorax, and pelvis about the x, y, and z-axes of the Cartesian coordinate system (Courtesy: CBP seminars).
Human posture described as translations of the head, thorax, and pelvis along the x, y, and z-axes of the Cartesian coordinate system (Courtesy: CBP seminars).
In an attempt to model the upright neutral sagittal spinal position, Don Harrison along with his son Deed Harrison and other colleagues performed a strategic set of studies. Although many research groups have attempted to model the shape of the normal human spine in the sagittal plane, few have done so as comprehensively and systematically as the Harrison group [4, 5, 6, 7, 8, 9, 10, 11]. Elliptical shape modeling of the path of the posterior longitudinal ligament along the posterior vertebral body margins was chosen due to the ease of clear identification of these spine landmark points and for the ability to easily make measurements of spine segmental and total angle of curvature on patient radiographs to compare patient measurements to model predictions. Modeling was performed on radiographic samples of asymptomatic participants. Computer iterations of spinal shape modeling was applied to determine best-fit geometric spine shapes by fitting various ellipses of altering minor-to-major axes ratios to digitized posterior vertebral body corners on samples of radiographs of the cervical [4, 5, 6], thoracic [7, 8], and lumbar spinal regions [9, 10, 11] (Figure 3).
Left: The Harrison normal spine model as the path of the posterior longitudinal ligament in the sagittal plane. Right: Harrison posterior tangent method are lines drawn contiguous with the posterior vertebral body margins used to quantify subluxation patterns (Courtesy: CBP seminars).
The Harrison normal spinal model (Figure 3) features a circular cervical lordosis, and portions of an elliptical curve for both the thoracic kyphosis (more curvature cephalad), and lumbar lordosis (more curvature caudad). Consequently, features of the normal human spine reveal that the opposite thoracic and lumbar curves meet together at the thoraco-lumbar junction being essentially straight; the upper, deeper curve of the upper thoracic spine reflects oppositely at the cervico-thoracic junction (between T1 and T2) and continues into the cervical lordosis; the lower lumbar spine increases its lordotic alignment having two-thirds of its curve between L4-S1 as it meets the forward tilted sacral base. The spine is modeled as vertical in the front view. The spine alignment is easily quantified by repeatable and reliable methods from measuring its position from standing X-rays [12, 13, 14, 15, 16] (Figure 3).
The Harrison normal spinal model has been validated in several ways. Simple analysis of alignment data on samples of the normal, asymptomatic population has been done [4, 5, 6, 7, 8, 9, 10, 11]. Comparison studies between normal samples to symptomatic samples [4, 17]; as well as between normal samples to theoretical ideal models have been done [4, 5, 8, 10]. The statistical differentiation of asymptomatic subjects from symptomatic pain group patients based on alignment data has been performed [6, 11]. The demonstration of paralleled spine alignment improvements with reductions in pain and disability, versus no change in untreated control groups in pre-post clinical trials have been performed [18, 19, 20, 21, 22, 23]. The demonstration in randomized clinical trials that only patient groups achieving lordosis and sagittal posture improvement (lumbar or cervical) achieve long-term improvements in various outcome measures versus comparative treatment groups not getting spine alignment improvement who experience regression in multiple outcome measures at follow-up have also been done [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35].
CBP technique is a full-spine posture and spine rehabilitation method that incorporates mirror image® (MI) exercises, adjustments, and traction applications in the restoration of normal/ideal spine alignment [1, 36, 37, 38]. Chiropractors and other manual therapists practicing CBP structural rehabilitation techniques have used this spine model as a structural goal of care for over 20 years. It is noted that this model serves as the baseline for generalized patient comparison, however, specific patient comparisons must include patient-specific considerations related to thoracic inlet parameters [39] as well as pelvic morphology [40] as these may dictate a structural modification to the sagittal plane model for a given patient [37]. There are software programs (i.e., PostureRay Inc., Trinity, FL, USA) that aid in the ability for practitioners to assess spine alignment quickly in daily practice (Figure 4).
Three patients demonstrating dramatically different spine alignment patterns. Left: Excessive lumbar hyperlordosis, L4 anterolisthesis, and excessive anterior sagittal balance in a mid-aged female with disabling low back pain; Middle: Excessive thoracolumbar kyphosis and early degenerative changes in a mid-aged male; Right: Excessive thoracic hyperkyphosis in a young male with Scheuermann’s disease. Red line is contiguous with posterior vertebral body margins; green line represents Harrison normal spinal model. (Courtesy: PAO).
Today the evidence supporting the CBP approach to the correction of cervical lordosis and lumbar lordosis is substantial. There are now many randomized controlled clinical trials (RCT) documenting the reduction of anterior head translation [24, 28, 29, 30, 31, 32, 33, 34, 35], as well as the increase in cervical lordosis [24, 28, 29, 30, 31, 32, 33, 34, 35], and the increase in lumbar lordosis [25, 26, 27] in patients presenting with hypolordosis in each of these spinal areas. These trials have also demonstrated that the postural and spinal improvements are associated with improvements in various patient outcomes, including: pain, disability, quality of life, range of motion as well as specific physiological measures such as improved neurological central conduction times—the ability of the brain to communicate with the body.
We will now address in different sections the CBP approach to the restoration of cervical lordosis and then the restoration of lumbar lordosis.
The first clinical trial using CBP methods for the restoration of cervical lordosis was a non-randomized controlled trial (nRCT) published in 1994 [18]. This first trial substantiated two trends: (1) Sagittal cervical alignment could be changed routinely, in patient cohorts receiving extension traction; (2) Spine alignment does not improve following spinal manipulative therapy (SMT) as a comparative group receiving spinal manipulation had no improvement in lordosis. Two other nRCTs were published in 2002 [20] and 2003 [21] confirming the results in the first trial and demonstrated that follow-up of patients experiencing improvements in lordosis by extension traction showed these improvements were relatively stable (small or no loss) at 14 [21] or 15.5 [20] months follow-up. These two latter trials also documented pain reductions coinciding with the lordosis improvements [20, 21] versus no improvements in untreated control groups.
More recently, Moustafa et al. [24, 28, 29, 30, 31, 32, 33, 34, 35] has performed multiple RCTs showing improvements in cervical lordosis with extension traction protocols as part of physiotherapeutic treatment programs. These trials have demonstrated superior long-term patient outcomes versus comparative patient groups who only receive the physiotherapy minus the extension traction. In fact, there is now good evidence substantiating CBP cervical extension traction protocols show long-term reduction of anterior head translation (Figure 5), long-term improvement in cervical lordosis (Figure 6), and long-term reduction in pain levels (Figure 7) versus treatments that are ‘cookie-cutter’ for the purpose of pain-relief.
Data from 3 RCTs demonstrates patients receiving cervical extension traction as well as conventional treatments have reduction of anterior head translation that is sustained for 1-year after stopping treatment versus the comparative groups (controls) remaining virtually unaffected by conventional treatments (Weighted averages from Moustafa et al. [
Data from 3 RCTs demonstrates patients receiving cervical extension traction as well as conventional treatments have lordosis improvements that are sustained for 1-year after stopping treatment versus the cervical curve of comparative groups (controls) remaining unaffected by conventional treatments (Weighted averages from Moustafa et al. [
Data from four RCTs demonstrates patients receiving cervical extension traction as well as conventional treatments have pain reductions that are sustained for 1-year after stopping treatment versus comparative groups (controls) who show a regression (increasing) of pain intensity towards baseline after stopping treatment (Weighted averages from Moustafa et al. [
Table 1 summarizes the main outcomes from eight separate RCTs on CBPs extension traction as part of physiotherapeutic treatment programs versus comparative groups only receiving the physiotherapy and not the extension traction. Notably, and as demonstrated in Figures 5–7, pain-relief treatment programs (i.e., stretching/strengthening exercises, infrared irradiation, spinal manipulation, myofascial release, TENS, mobilization, hot packs – not including extension traction) do not improve the spinal parameters and only provide short-term pain relief that regresses after the cessation of treatment.
Summary of eight RCTs documenting results in cervical lordosis improvements and reduction of anterior head translation corresponding with various pain, disability, quality of life and physiological parameter improvements.
The classic CBP “E-A-T” protocol includes Exercises, spinal Adjustments, and Traction in a MI application. Corrective exercises for a cervical spine that is hypolordotic/kyphotic includes cervical extension exercises (Figure 8). A new patient may begin with head extension exercises in mid-air, and then progress to using a resistance band placed at the mid/low neck at the apex of their curve abnormality. Repetitions may vary but may begin at 25 and increase to 50 or 100. The patient may be instructed to hold each repetition for 3–5 s [36, 37]. After the patient sufficiently demonstrates proficiency, prescription for home exercises should be made.
Cervical extension traction. Bottom right: Cervical extension exercises with resistance band (Courtesy: CBP seminars).
The rationale for corrective exercises is to strengthen the weak muscles, and stretch the shortened muscles as presumably the patient has had the spinal misalignment for some time, usually many years, and the soft tissues will have, over time, adapted to the poor posture [41]. It is generally accepted that exercises alone will not lead to any substantial improvement in lordosis or decreased head translation, but are still important in order to provide stability to the spinal area as the patient is being simultaneously treated with passive spinal traction as part of the CBP rehabilitation program.
Although many CBP practitioners provide spinal manipulative therapy, the MI approach to treat a patient having cervical hypolordosis/kyphosis includes cervical hyperextension drop-table adjustments. The rationale for the application of these force vectors are to reset the tone of the postural muscles [42]. More often patients presenting with cervical spine hypolordosis or kyphosis have accompanying anterior head translation. For this reason, it is commonplace for the manual therapist to place the patient in the prone position and elevate the head support to position the patient in the MI. At the same time the patient can extend their neck backwards (i.e., look forward and place their chin on the head support) to further place the spine into a hyperextended position. The manual therapist would place their contact hand at the mid-neck and/or on the upper thoracic spine and provide a force downwards to engage the drop-piece on a “drop-table.”
Spinal traction is applied to increase the cervical lordosis and the spine must be placed in a hyperextended position (Figure 8). There are several extension traction variations; each is specific to the actual cervical alignment. For example, a cervical kyphosis with evident anterior head translation requires a posterior head translation and a “2-way” extension traction set-up [20], while a kyphosis without significant anterior head translation could be sufficiently reduced using a “Pope 2-way” extension traction without posterior head translation [21]. A patient having significant AHT having hypolordosis (but no kyphosis) should have sufficient reduction of AHT and increase in lordosis receiving extension-compression extension traction [18]. Initially, traction should be performed for 3–5 min and progress to 10–20 min per treatment session.
The first clinical trial using CBP methods for the restoration of lumbar lordosis was a non-randomized trial in 2002 [19]. In this trial, 48 patients with chronic low back pain (CLBP) were treated with SMT and extension traction to the lumbar spine for an average of 36 treatment sessions over an average of 12 weeks. There was an average of an 11.3° increase in lumbar lordosis from L1-L5 ARA (9.1° increase from T12-S1 Cobb). A control group of 30 CLBP patients had no pain reduction and no improvement in spine parameters. This trial demonstrated, for the lumbar spine with CLBP patients having hypolordosis, that routine increases in lumbar curvature is achievable; patients who get no treatment have no increase in lumbar curve and remain in pain. Harrison et al. concluded: “This new method of lumbar extension traction is the first nonsurgical rehabilitative procedure to show increases in lumbar lordosis in chronic LBP subjects with hypolordosis.”
Since the original trial outlining the CBP extension traction approach for lumbar hypolordosis, two more randomized controlled trials have documented that superior outcomes occur in mechanical LBP and sciatic patients receiving lumbar extension traction as part of comprehensive physiotherapeutic programs versus those who receive the physiotherapy without the extension traction (Figures 9 and 10) [25, 26, 27]. These results mirror the outcomes as found from the trials on the cervical spine by CBP extension traction methods [24, 28, 29, 30, 31, 32, 33, 34, 35]. Table 2 summarizes the two lumbar trials [25, 26, 27].
Data from two RCTs demonstrates patients receiving lumbar extension traction as well as conventional treatments have lordosis improvements that are sustained for 6-months after stopping treatment versus the lumbar curve of comparative groups (controls) remaining unaffected by conventional treatments (Weighted averages from Moustafa et al. [
Data from two RCTs demonstrates patients receiving lumbar extension traction as well as conventional treatments have pain reductions that are sustained for 6-months after stopping treatment versus comparative groups (controls) who show a regression (increasing) of pain intensity towards baseline after stopping treatment (Weighted averages from Moustafa et al. [
Summary of two RCTs documenting results in lumbar lordosis improvements corresponding with various pain, disability, quality of life and physiological parameter improvements.
Low back disorder patients who concurrently have lumbar hypolordosis require lumbar extension traction to increase their lumbar structural mal-alignment. Figure 11 shows three different positions for the application of lumbar extension traction. Although there is not yet enough research to suggest one method over the other, the choice is up to the doctor/therapist. It is suggested that those having high intensity pain and/or those who are older and frail and/or those with balance and locomotor challenges perform lumbar traction in the supine position.
Lumbar extension traction as preformed in the seated, standing and supine positions (Courtesy: CBP seminars).
Similar to that discussed for the cervical spine, initial traction should be for 3–5 min and progress to 10–20 min per treatment session [19, 25, 26, 27]. Simultaneous physiotherapeutic treatments, including SMT, are in order to provide initial pain relief and improved mobility so that the patient is able to tolerate the traction [36, 37, 38].
Spinal traction has been around for literally hundreds of years. The unique aspect of CBP’s traction for the purpose of increasing the physiologic lordosis whether for the cervical or lumbar spinal areas is performing traction in a hyperextended position. The key to significant structural spine alignment changes lays in the viscoelastic creep properties of the intervertebral disk (and ligaments) and myofascial tissues under therapeutic conditions [43].
Recently, Harrison and Oakley asked the question:
It is presumed that hyperextension traction targets the anterior portion of the discs, the anterior longitudinal ligament, and anterior column musculature specifically [36, 37]. Traction must be performed in a sustained and continuous manner for creep-relaxation and visco-elastic deformation to occur [45, 46, 47, 48, 49]. Thus, the biomechanical elongation of the anterior structures leads to a permanent structural tissue resting length change and when performed in a frequent manner (i.e., daily or three times per week), a steady and consistent change to the spine alignment will occur as has been demonstrated by CBP for increasing the cervical lordosis by an average of 10–18° [18, 20, 21, 24, 28, 29, 30, 31, 32, 33, 34, 35] and lumbar lordosis by an average of 7–11° [19, 25, 26, 27, 44] over the duration of 10-14 weeks. Note that the amount of change in the cervical and lumbar lordosis were measured radiographically on follow-up spine X-rays using standardized, reliable, and valid measurement methods [18, 20, 21, 24, 28, 29, 30, 31, 32, 33, 34, 35].
Although strict CBP technique methods incorporate exercises, spinal adjustments and spinal traction (E-A-T), these protocols have been discussed elsewhere [1, 36, 37, 38]. We will outline the critical protocol parameters that apply specifically to extension traction.
A patient must be screened for the presence of spinal hypolordosis in the cervical or lumbar spine by standard standing X-ray. External (non-imaging methods) body measurements are not valid for the assessment of the magnitude, segmental contributions, and geometric shape of a patient’s lumbar or cervical lordosis. Furthermore, only direct spine imaging allows the visualization and quantification of a patients pelvic and thoracic inlet morphologies which are known variables that influence the magnitude of sagittal curvature that should be present and can be achieved through rehabilitation [37, 39, 40]. In the majority of cases, all radiographs should be taken with the patient in a standardized position, standing freely without support, with arms fully flexed with the hands in the clavicle position [50, 51]. We recommend the feet to be positioned hip-widths apart without any shoes as well as the patient should have their eyes open and be staring straight ahead at eye level. Although full spine 36-inch lateral views may be used, it is recommended that a dedicated lateral cervical be taken to more accurately assess cervical subluxation as the 36-inch view projects the head more posteriorly and the cervical spine flatter [52, 53]. An obvious concern about routine X-rays is the exposure to radiation, we address this issue in the next section.
Although various measurement methods may be used, we recommend the Harrison posterior vertebral body tangent method as it is highly reliable (small standard error of measurement; i.e., <2° for regional measures of C2-7 and L1-5) [12, 13, 14, 15]. Although C2-T1 absolute rotation angle (ARA) can be used, typically C2-C7 ARA is standard for measuring the cervical lordosis and L1-L5 ARA for the lumbar lordosis.
A patient may start traction for only 3–5 min initially. Increasing traction time may progress by 1–3 min on subsequent treatments pending their clinical tolerance and response. Total traction time should be between 10 to 20 min maximum. There is no significant benefit to performing traction longer than 20 min as the majority of visco-elastic creep deformation occurs in this time [48].
Typical treatment plans include seeing a patient three-times per week for 10–12 weeks prior to a repeat X-ray and analysis of structural improvement. As outlined in previous works [36, 37, 38], a patient may require several rounds of treatments to achieve a spinal alignment in the realm of normal/ideal; this is particularly true for patients having gross spinal deformities, high pain levels, and disability, as demonstrated in the treatment of non-iatrogenic flat back [44]. It is not untypical to treat a Patient three times per week, for 6–12 months in these cases.
Generally, contraindications for extension traction protocols are the same as contraindications for SMT. Although traction protocols may be used in these cases, patients with a history of stroke, high blood pressure, bone spurring on the posterior aspect of the spine, spinal stenosis or other space occupying lesions represent potential high-risk, and therefore, extra caution should be taken to screen these patients for tolerance to this type of traction.
Patient screening for the ability to tolerate spinal extension traction should be performed for all patients. This typically includes assessing tolerance while laying supine on an extension traction device (e.g., Denneroll). The patient should be assessed for distress and/or an exacerbation of symptoms including the reporting of nausea, dizziness or increased pain. Those with rigid spine deformities and/or spinal osteoarthritis should have a stress view radiograph taken for flexion-extension as well as lying supine over an extension traction device.
The following represent absolute contraindications to the application of spinal extension traction [36, 37]:
Pregnancy, especially in later stages nearing term;
Infectious discitis and spinal tumors compromising vertebral stability;
Abdominal aortic aneurysm;
Severe osteoporosis and other bone diseases;
Unstable vertebral fraction;
Unstable segment under loading (verified by radiography) that cannot be reduced with extension traction loading;
Multi-level spinal fusion;
Recent spinal surgery;
Abdominal hernias for lumbar traction;
Other conditions that would be contraindicated for spinal manipulation;
Patient having hyperlordosis of the cervical or lumbar spinal areas where extension traction is to be performed;
Not having recent confirmatory standing X-rays of the spinal region to where the extension traction is to be applied.
The following represent relative contraindications to spinal extension traction that require diligent screening and clinical evaluation [36, 37]:
Canal stenosis—although also proven useful for this [54];
Spondylolisthesis—although also proven useful for this [55];
Single-level fusions—to prevent hyperextension at the adjacent segment to the fusion;
Hip replacement;
Advanced osteoporosis;
Locking (hyperextension) of the knees while in standing traction position—this may limit blood flow and induce syncope;
Lack of food/nutrition and/or water several hours prior to treatment—may result in syncope;
Extreme fatigue or illness or recently donating blood—may result in syncope;
When pelvic morphology dictates a modification from ideal lumbar lordosis or thoracic inlet angle dictates a modification from ideal cervical lordosis such that the patient’s actual lordosis is more or less than expected [36, 37, 39, 40];
Kissing spinous’s or Baastrup’s disease will inhibit segmental extension from occurring.
When applying extension traction protocols, it is important to realize the obvious notion that this applies only to those presenting with hypolordosis, straightening, or kyphosis of the cervical or Lumbar spinal areas, not to those with hyperlordosis. In such cases, different CBP traction protocols apply which are beyond the scope of this brief review [39, 56]. Also, in the performance of assessing patient tolerance to extension traction, the slow progression of increasing time and transitioning to a more challenging extension stretch is found in the skill and art of the hands of the practitioner. Fortunately, extension traction protocols have been proven safe as no reports of deleterious outcomes have been reported in the multiple RCT’s [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35]. Further, this approach seems so safe that once thought of as contraindications, for example spondylolisthesis, have been shown to be able to be reduced by a special application of these methods [55]. Again, the experience and confidence of the practitioner will dictate whether this approach is selected for different candidate patients with their corresponding varying levels of difficult spinal conditions and case histories.
Concerns over radiation exposures during routine spinal X-ray imaging need discussion. Although this topic has been thoroughly discussed elsewhere [57, 58, 59, 60], in brief, patient exposures from spinal X-rays are not harmful. First, the assumption that radiation exposures from low-doses are carcinogenic is false; low-doses of radiation (including X-rays and CT scans) stimulate the adaptive protection systems in the body to “over-repair” any genetic damage done, including DNA double strand breaks by imaging [61]. Second, because of point one, there is no cumulative effect; therefore, the only relative risk can be considered from a single session of X-rays (i.e., 1–3 mGy) [57, 58]. Third, due to point two, the amount of radiation from X-rays of 1–3 mGy is many times lower than the recognized dose threshold for leukemia of 1100 mGy (95% CI: 500–2600 mGy) [57, 62] and therefore cannot be carcinogenic.
Today there are reliable and predictable means through application of extension spinal traction as part of comprehensive rehabilitation programs to restore the natural curvatures of the spine. High-quality evidence points to CBP methods as offering superior long-term outcomes for treating patients with sagittal plane spine and posture deformities who present with various craniocervical and lumbosacral disorders.
PAO is a paid consultant to CBP; DEH sells products related to the treatment of spine deformity as depicted herein.
anterior head translation
absolute rotation angle
chiropractic BioPhysics®
chronic low back pain
exercises, adjustments, traction (mirror image)
low back pain
mirror image®
non-randomized controlled trial
randomized controlled trial
spinal manipulative therapy
Ove Odredbe i uvjeti ističu pravila i regulacije u svezi korištenja IntechOpenove stranice www.intechopen.com i svih poddomena u vlasništvu IntechOpena, tvrtke sa sjedištem u 5 Princes Gate Court, London, SW7 2QJ, Ujedinjeno Kraljevstvo.
',metaTitle:"Odredbe i uvjeti",metaDescription:"Ove Odredbe i uvjeti ističu pravila i regulacije u svezi korištenja IntechOpenove stranice www.intechopen.com i svih poddomena u vlasništvu IntechOpena, tvrtke sa sjedištem u 5 Princes Gate Court, London, SW7 2QJ, Ujedinjeno Kraljevstvo.",metaKeywords:null,canonicalURL:"/page/cro-terms-and-conditions",contentRaw:'[{"type":"htmlEditorComponent","content":"Pristupom na stranicu www.intechopen.com slažete se s ovim odredbama, sa svim primjenjivim zakonskim odredbama, te se slažete s poštovanjem svih lokalnih zakona. Korištenje i/ili pristup ovoj stranici temelji se na potpunom prihvaćanju ovih odredbi. Svi materijali na ovoj stranici zaštićeni su primjenjivim zakonima o autorskim pravima i žigu.
\\n\\nSljedeća terminologija odnosi se na Odredbe i uvjete, te na sve naše ugovore:
\\n\\nKlijent, stranka, vi, vaš odnosi se na vas, osobu koja pristupa ovoj stranici i prihvaća IntechOpenove Odredbe i uvjete;
\\n\\nKompanija, tvrtka, mi, naše odnosi se na tvrtku IntechOpen;
\\n\\nStranke, strane odnosi se na klijenta i na nas, ili samo na klijenta ili nas.
\\n\\nSve odredbe koje se odnose na ponudu, prihvat ili razmatranje plaćanja, a za koja mi pružamo asistenciju klijentu, bilo na ugovoreni ili fiksni način, a s ciljem da se ostvare potrebe i želje klijenta u svezi s našim uslugama, su podložne zakonskim odredbama Ujedinjenog Kraljevstva.
\\n\\nOsim ako nije suprotno navedeno, IntechOpen i/ili svi davatelji licence vlasnici su intelektualnog vlasništva nad svim materijalima na www.intechopen.com. Sva prava intelektualnog vlasništva su pridržana. Stranice sa www.intechopen.com možete gledati, preuzimati, dijeliti, dijeliti poveznice i printati za osobnu uporabu, a temeljem pravila sadržanih u ovim Odredbama i uvjetima.
\\n\\nMi koristimo kolačiće. Korištenjem IntechOpenove stranice slažete se s korištenjem kolačića u skladu s IntechOpenovom Politikom privatnosti. Većina modernih, interaktivnih stranica koristi kolačiće kako bi omogućila ponovno pronalaženje korisničkih detalja kod svakog posjeta. Na našoj stranici kolačići se uglavnom koriste kako bi omogućili funkcionalnost i olakšali posjetiteljima korištenje stranice.
\\n\\nIntechOpen ili njegovi suradnici niti u jednom slučaju neće biti odgovorni za štete (štete uključuju gubitak podataka ili profita, druge poslovne prekide, te sve ostale štete) koje nastanu zbog korištenja materijala na IntechOpenovoj stranici ili nemogućnosti da se iste koriste, čak i ako je IntechOpen ili njegov predstavnik o takvoj šteti obaviješten pismenim ili usmenim putem. Neke jurisdikcije ne dozvoljavaju ograničenja garancija ili ograničenja obveza za posljedične ili slučajne štete pa se u tom slučaju ova ograničenja možda ne odnose na vas.
\\n\\nMaterijali koji se pojavljuju na IntechOpenovoj stranici mogu sadržavati manje greške, tipfelere ili fotografske greške. IntechOpen može napraviti promjene na bilo kojem materijalu koji se nalazi na stranici u bilo koje vrijeme.
\\n\\nIntechOpen nije formalno povezan niti s jednom vanjskom stranicom čije poveznice vode na www.intechopen.com, osim ako to nije izravno navedeno. Iz tog razloga IntechOpen nije odgovoran za sadržaj koji se pojavljuje na takvim stranicama. Poveznica na IntechOpenovu stranicu ne implicira povezanost sa IntechOpenom. Korištenje takvih poveznica isključiva je odgovornost korisnika.
\\n\\nZadržavamo pravo vlasništva nad cjelokupnom stranicom www.intechopen.com i nad svim materijalom na toj stranici. Koristeći se našim uslugama, slažete se da maknete sve poveznice na našu stranicu odmah nakon što to od vas zatražimo. Također, zadržavamo pravo da ove Odredbe i uvjete, i politiku o poveznicama izmjenimo u bilo koje vrijeme. Koristeći se poveznicama na naše stranice slažete se s ovim Odredbama i uvjetima.
\\n\\nAko smatrate da je bilo koja poveznica na našoj stranici sumnjiva iz bilo kojeg razloga, molimo vas da nas kontaktirate. U tom slučaju razmotrit ćemo micanje poveznice s naše stranice, iako nismo obvezni to napraviti.
\\n\\nBez prethodne privole i izričite pisane dozvole, ne možete stvarati okvire oko naših stranica ili koristiti druge tehnike koje na bilo koji način mogu promijeniti prezentaciju ili izgled naše stranice.
\\n\\nIntechOpen može ove Odredbe izmijeniti u bilo koje vrijeme i bez prethodne obavijesti. Koristeći ovu stranicu vi se slažete s trenutnim Odredbama i uvjetima koje su na snazi.
\\n\\nOve Odredbe i uvjeti su sastavljeni u skladu s odredbama prava Ujedinjenog Kraljevstva, a za sve sporove nadležan je sud u Londonu, Ujedinjeno Kraljevstvo.
\\n"}]'},components:[{type:"htmlEditorComponent",content:"Pristupom na stranicu www.intechopen.com slažete se s ovim odredbama, sa svim primjenjivim zakonskim odredbama, te se slažete s poštovanjem svih lokalnih zakona. Korištenje i/ili pristup ovoj stranici temelji se na potpunom prihvaćanju ovih odredbi. Svi materijali na ovoj stranici zaštićeni su primjenjivim zakonima o autorskim pravima i žigu.
\n\nSljedeća terminologija odnosi se na Odredbe i uvjete, te na sve naše ugovore:
\n\nKlijent, stranka, vi, vaš odnosi se na vas, osobu koja pristupa ovoj stranici i prihvaća IntechOpenove Odredbe i uvjete;
\n\nKompanija, tvrtka, mi, naše odnosi se na tvrtku IntechOpen;
\n\nStranke, strane odnosi se na klijenta i na nas, ili samo na klijenta ili nas.
\n\nSve odredbe koje se odnose na ponudu, prihvat ili razmatranje plaćanja, a za koja mi pružamo asistenciju klijentu, bilo na ugovoreni ili fiksni način, a s ciljem da se ostvare potrebe i želje klijenta u svezi s našim uslugama, su podložne zakonskim odredbama Ujedinjenog Kraljevstva.
\n\nOsim ako nije suprotno navedeno, IntechOpen i/ili svi davatelji licence vlasnici su intelektualnog vlasništva nad svim materijalima na www.intechopen.com. Sva prava intelektualnog vlasništva su pridržana. Stranice sa www.intechopen.com možete gledati, preuzimati, dijeliti, dijeliti poveznice i printati za osobnu uporabu, a temeljem pravila sadržanih u ovim Odredbama i uvjetima.
\n\nMi koristimo kolačiće. Korištenjem IntechOpenove stranice slažete se s korištenjem kolačića u skladu s IntechOpenovom Politikom privatnosti. Većina modernih, interaktivnih stranica koristi kolačiće kako bi omogućila ponovno pronalaženje korisničkih detalja kod svakog posjeta. Na našoj stranici kolačići se uglavnom koriste kako bi omogućili funkcionalnost i olakšali posjetiteljima korištenje stranice.
\n\nIntechOpen ili njegovi suradnici niti u jednom slučaju neće biti odgovorni za štete (štete uključuju gubitak podataka ili profita, druge poslovne prekide, te sve ostale štete) koje nastanu zbog korištenja materijala na IntechOpenovoj stranici ili nemogućnosti da se iste koriste, čak i ako je IntechOpen ili njegov predstavnik o takvoj šteti obaviješten pismenim ili usmenim putem. Neke jurisdikcije ne dozvoljavaju ograničenja garancija ili ograničenja obveza za posljedične ili slučajne štete pa se u tom slučaju ova ograničenja možda ne odnose na vas.
\n\nMaterijali koji se pojavljuju na IntechOpenovoj stranici mogu sadržavati manje greške, tipfelere ili fotografske greške. IntechOpen može napraviti promjene na bilo kojem materijalu koji se nalazi na stranici u bilo koje vrijeme.
\n\nIntechOpen nije formalno povezan niti s jednom vanjskom stranicom čije poveznice vode na www.intechopen.com, osim ako to nije izravno navedeno. Iz tog razloga IntechOpen nije odgovoran za sadržaj koji se pojavljuje na takvim stranicama. Poveznica na IntechOpenovu stranicu ne implicira povezanost sa IntechOpenom. Korištenje takvih poveznica isključiva je odgovornost korisnika.
\n\nZadržavamo pravo vlasništva nad cjelokupnom stranicom www.intechopen.com i nad svim materijalom na toj stranici. Koristeći se našim uslugama, slažete se da maknete sve poveznice na našu stranicu odmah nakon što to od vas zatražimo. Također, zadržavamo pravo da ove Odredbe i uvjete, i politiku o poveznicama izmjenimo u bilo koje vrijeme. Koristeći se poveznicama na naše stranice slažete se s ovim Odredbama i uvjetima.
\n\nAko smatrate da je bilo koja poveznica na našoj stranici sumnjiva iz bilo kojeg razloga, molimo vas da nas kontaktirate. U tom slučaju razmotrit ćemo micanje poveznice s naše stranice, iako nismo obvezni to napraviti.
\n\nBez prethodne privole i izričite pisane dozvole, ne možete stvarati okvire oko naših stranica ili koristiti druge tehnike koje na bilo koji način mogu promijeniti prezentaciju ili izgled naše stranice.
\n\nIntechOpen može ove Odredbe izmijeniti u bilo koje vrijeme i bez prethodne obavijesti. Koristeći ovu stranicu vi se slažete s trenutnim Odredbama i uvjetima koje su na snazi.
\n\nOve Odredbe i uvjeti su sastavljeni u skladu s odredbama prava Ujedinjenog Kraljevstva, a za sve sporove nadležan je sud u Londonu, Ujedinjeno Kraljevstvo.
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13389},{group:"region",caption:"Middle and South America",value:2,count:11662},{group:"region",caption:"Africa",value:3,count:4168},{group:"region",caption:"Asia",value:4,count:22333},{group:"region",caption:"Australia and Oceania",value:5,count:2019},{group:"region",caption:"Europe",value:6,count:33644}],offset:12,limit:12,total:135278},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish",topicId:"161925"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:22},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:15},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:37},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:8},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:8},{group:"topic",caption:"Medicine",value:16,count:61},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:0},popularBooks:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3737",title:"MATLAB",subtitle:"Modelling, Programming and Simulations",isOpenForSubmission:!1,hash:null,slug:"matlab-modelling-programming-and-simulations",bookSignature:"Emilson Pereira Leite",coverURL:"https://cdn.intechopen.com/books/images_new/3737.jpg",editors:[{id:"12051",title:"Prof.",name:"Emilson",middleName:null,surname:"Pereira Leite",slug:"emilson-pereira-leite",fullName:"Emilson Pereira Leite"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1770",title:"Gel Electrophoresis",subtitle:"Principles and Basics",isOpenForSubmission:!1,hash:"279701f6c802cf02deef45103e0611ff",slug:"gel-electrophoresis-principles-and-basics",bookSignature:"Sameh Magdeldin",coverURL:"https://cdn.intechopen.com/books/images_new/1770.jpg",editors:[{id:"123648",title:"Dr.",name:"Sameh",middleName:null,surname:"Magdeldin",slug:"sameh-magdeldin",fullName:"Sameh Magdeldin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4797},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7175,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1981,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",publishedDate:"July 20th 2022",numberOfDownloads:2308,editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1473,editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",publishedDate:"April 26th 2011",numberOfDownloads:318571,editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",publishedDate:"September 26th 2012",numberOfDownloads:271836,editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",publishedDate:"July 1st 2013",numberOfDownloads:243450,editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",publishedDate:"July 20th 2022",numberOfDownloads:1582,editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",publishedDate:"July 13th 2022",numberOfDownloads:2082,editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",publishedDate:"October 17th 2012",numberOfDownloads:256294,editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10778",title:"Model-Based Control Engineering",subtitle:"Recent Design and Implementations for Varied Applications",isOpenForSubmission:!1,hash:"e39a567d9b6d2a45d0a1d927362c9005",slug:"model-based-control-engineering-recent-design-and-implementations-for-varied-applications",bookSignature:"Umar Zakir Abdul Hamid and Ahmad `Athif Mohd Faudzi",coverURL:"https://cdn.intechopen.com/books/images_new/10778.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"268173",title:"Dr.",name:"Umar Zakir Abdul",middleName:null,surname:"Hamid",slug:"umar-zakir-abdul-hamid",fullName:"Umar Zakir Abdul Hamid"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11308",title:"Selected Topics on Infant Feeding",subtitle:null,isOpenForSubmission:!1,hash:"213c3e403327a2919eca1dc5e82a0ec3",slug:"selected-topics-on-infant-feeding",bookSignature:"Isam Jaber AL-Zwaini and Haider Hadi AL-Musawi",coverURL:"https://cdn.intechopen.com/books/images_new/11308.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"30993",title:"Prof.",name:"Isam Jaber",middleName:null,surname:"Al-Zwaini",slug:"isam-jaber-al-zwaini",fullName:"Isam Jaber Al-Zwaini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11139",title:"Geochemistry and Mineral Resources",subtitle:null,isOpenForSubmission:!1,hash:"928cebbdce21d9b3f081267b24f12dfb",slug:"geochemistry-and-mineral-resources",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11139.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"993",title:"Pre-Hospital Emergency Medicine",slug:"critical-care-medicine-pre-hospital-emergency-medicine",parent:{id:"173",title:"Critical Care Medicine",slug:"critical-care-medicine"},numberOfBooks:3,numberOfSeries:0,numberOfAuthorsAndEditors:69,numberOfWosCitations:18,numberOfCrossrefCitations:13,numberOfDimensionsCitations:22,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"993",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"5970",title:"Bedside Procedures",subtitle:null,isOpenForSubmission:!1,hash:"ba56d3036ac823a7155f40e4a02c030d",slug:"bedside-procedures",bookSignature:"Gabriel Cismaru",coverURL:"https://cdn.intechopen.com/books/images_new/5970.jpg",editedByType:"Edited by",editors:[{id:"191888",title:"Dr.",name:"Gabriel",middleName:null,surname:"Cismaru",slug:"gabriel-cismaru",fullName:"Gabriel Cismaru"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5756",title:"Intensive Care",subtitle:null,isOpenForSubmission:!1,hash:"c15f872f6c0158a19bf64f081fe1e854",slug:"intensive-care",bookSignature:"Nissar Shaikh",coverURL:"https://cdn.intechopen.com/books/images_new/5756.jpg",editedByType:"Edited by",editors:[{id:"107703",title:"Dr.",name:"Nissar",middleName:null,surname:"Shaikh",slug:"nissar-shaikh",fullName:"Nissar Shaikh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5220",title:"Oncology Critical Care",subtitle:null,isOpenForSubmission:!1,hash:"6ca48669ac7afaf59398a958335eff65",slug:"oncology-critical-care",bookSignature:"Jeffrey B. Hoag",coverURL:"https://cdn.intechopen.com/books/images_new/5220.jpg",editedByType:"Edited by",editors:[{id:"91738",title:"Dr.",name:"Jeffrey",middleName:null,surname:"Hoag",slug:"jeffrey-hoag",fullName:"Jeffrey Hoag"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:3,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"52089",doi:"10.5772/64372",title:"Infections in Cancer Patients",slug:"infections-in-cancer-patients",totalDownloads:2569,totalCrossrefCites:4,totalDimensionsCites:5,abstract:"Cancer therapy is a dynamically evolving field. Chemotherapy and biologic agents impact the magnitude and duration of immunosuppression in the already-immunocompromised cancer hosts who are then susceptible to a broad spectrum of infectious complications ranging from mild opportunistic infections to severe, fatal neutropenic sepsis. Numerous bacterial, fungal, and viral organisms have been implicated dictating varied preventative approaches. Rapid assessment and risk stratification of febrile patients identify individuals requiring hospital admission. Timely delivery of antimicrobials reduces the risk of complications and death. Herein, we summarize the current “state of art” in the management of infection in the cancer patient. We detail the advances in antibacterial and antifungal therapy.",book:{id:"5220",slug:"oncology-critical-care",title:"Oncology Critical Care",fullTitle:"Oncology Critical Care"},signatures:"Deepjot Singh and Robert A. Bonomo",authors:[{id:"181936",title:"Dr.",name:"Deepjot",middleName:null,surname:"Singh",slug:"deepjot-singh",fullName:"Deepjot Singh"},{id:"187145",title:"Dr.",name:"Robert",middleName:null,surname:"Bonomo",slug:"robert-bonomo",fullName:"Robert Bonomo"}]},{id:"55443",doi:"10.5772/intechopen.68630",title:"Aneurysmal Subarachnoid Hemorrhage",slug:"aneurysmal-subarachnoid-hemorrhage",totalDownloads:2940,totalCrossrefCites:1,totalDimensionsCites:3,abstract:"Aneurysmal subarachnoid hemorrhage (SAH) is a devastating neurological syndrome, which occurs at a rate of 3–25 per 100,000 population. Smoking and hypertension are the most important risk factors of subarachnoid hemorrhage. Rupture of cerebral aneurysm leads to rapid spread of blood into cerebrospinal fluid and subsequently leads to sudden increase of intracranial pressure and severe headache. Subarachnoid hemorrhage is associated with neurological (such as re‐bleeding and vasospasm) and systemic (such as myocardial injury and hyponatremia) complications that are causes of high mortality and morbidity. Although patients with poor‐grade subarachnoid hemorrhage are at higher risk of neurological and systemic complications, the early and aggressive management of this group of patient has decreased overall mortality by 17% in last 40 years. Early aneurysm repair, close monitoring in dedicated neurological intensive care unit, prevention, and aggressive management of medical and neurological complications are the most important strategies to improve outcome.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Adel E. Ahmed Ganaw, Abdulgafoor M. Tharayil, Ali O. Mohamed\nBel Khair, Saher Tahseen, Jazib Hassan, Mohammad Faisal Abdullah\nMalmstrom and Sohel Mohamed Gamal Ahmed",authors:[{id:"198979",title:"Dr.",name:"Saher",middleName:null,surname:"Tahseen",slug:"saher-tahseen",fullName:"Saher Tahseen"},{id:"199923",title:"Dr.",name:"Adel. E. Ahmad",middleName:null,surname:"Ganaw",slug:"adel.-e.-ahmad-ganaw",fullName:"Adel. E. Ahmad Ganaw"},{id:"200584",title:"Dr.",name:"Abdulgafoor",middleName:null,surname:"Tharayil",slug:"abdulgafoor-tharayil",fullName:"Abdulgafoor Tharayil"},{id:"205193",title:"Dr.",name:"Ali",middleName:"O Mohamed",surname:"Bel Khair",slug:"ali-bel-khair",fullName:"Ali Bel Khair"},{id:"205194",title:"Dr.",name:"Jazib",middleName:null,surname:"Hassan",slug:"jazib-hassan",fullName:"Jazib Hassan"},{id:"205195",title:"Dr.",name:"M. Faisal",middleName:null,surname:"Malmstrom",slug:"m.-faisal-malmstrom",fullName:"M. Faisal Malmstrom"},{id:"205787",title:"Dr.",name:"Sohel Mohamed Gamal",middleName:null,surname:"Ahmed",slug:"sohel-mohamed-gamal-ahmed",fullName:"Sohel Mohamed Gamal Ahmed"}]},{id:"56878",doi:"10.5772/intechopen.70498",title:"Lumbar Puncture of the Newborn",slug:"lumbar-puncture-of-the-newborn",totalDownloads:1462,totalCrossrefCites:1,totalDimensionsCites:3,abstract:"Heinrich Irenäus Quincke was the first person in medical history to perform lumbar puncture (LP). Indications of lumbar puncture include suspected meningitis, suspected subarachnoid hemorrhage, administration of chemotherapeutic agents, instillation of contrast media for imaging of the spinal cord, and the evaluation of various neurologic conditions including normal pressure hydrocephalus and Guillain-Barré syndrome, and the treatment of idiopathic intracranial hypertension. Contraindications of lumbar puncture include findings of increased intracranial pressure, bleeding diathesis, cardiopulmonary instability, soft tissue infection at the puncture site, shock, respiratory insufficiency, and suspected meningococcal septicemia with extensive or spreading purpura. Altered mental status, focal neurologic signs, papilledema, focal seizure, and risk for brain abscess are indications for cranial imaging before performing LP. Lack of local anesthetic use and advancement of the spinal needle with the stylet in place were most prominent risk factors for a traumatic LP. Ultrasound may minimize the number of LP attempts and decrease patient and parent anxiety by easily identifying an insertion site. Infection, spinal hematoma, epidermoid tumor, and cerebral herniation are the main complications of LP. When LP is traumatic, the wisest approach is to assume the patient is having meningitis and start empirical therapy.",book:{id:"5970",slug:"bedside-procedures",title:"Bedside Procedures",fullTitle:"Bedside Procedures"},signatures:"Selim Öncel",authors:[{id:"200133",title:"Associate Prof.",name:"Selim",middleName:null,surname:"Öncel",slug:"selim-oncel",fullName:"Selim Öncel"}]},{id:"54793",doi:"10.5772/intechopen.68308",title:"Intensive Care Unit Workforce: Occupational Health and Safety",slug:"intensive-care-unit-workforce-occupational-health-and-safety",totalDownloads:2221,totalCrossrefCites:1,totalDimensionsCites:2,abstract:"There are many different work tasks and workplace hazards related to the ICU setting. The workplace hazards include the physical environment of the ICU, working conditions, psychosocial factors, ergonomic factors, biological factors and chemical factors that cause ICU workers to have health problems. The occurrence of occupational health problems in ICU workers not only leads to decreased job satisfaction and productivity but also increases absenteeism and burnout. Moreover, this situation adversely affects patient care and increases the cost of treatment. Recognising occupational hazards and risks arising from the work environment will assist in planning strategies to protect and promote health programmes for ICU workers. Understanding the importance of occupational health and safety practices by all institutions is a key factor to improve quality of life, work efficiency and work satisfaction of ICU workers.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Melek Nihal Esin and Duygu Sezgin",authors:[{id:"183522",title:"Prof.",name:"Melek Nihal",middleName:null,surname:"Esin",slug:"melek-nihal-esin",fullName:"Melek Nihal Esin"},{id:"197030",title:"Dr.",name:"Duygu",middleName:null,surname:"Sezgin",slug:"duygu-sezgin",fullName:"Duygu Sezgin"}]},{id:"54955",doi:"10.5772/intechopen.68348",title:"Acute Kidney Injury in the Intensive Care Unit",slug:"acute-kidney-injury-in-the-intensive-care-unit",totalDownloads:2452,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Acute kidney injury (AKI) is defined as an abrupt decrease in glomerular filtration rate (GFR). Incidence varies from 20% to as high as 70% in critically ill patients. Classically, AKI has been divided into three broad pathophysiologic categories: prerenal AKI, intrinsic AKI, and postrenal (obstructive) AKI. The clinical manifestations of AKI vary among a wide range of symptoms and metabolic abnormalities. A sudden decrease in GFR will result in rising concentrations of solutes in the blood, which are normally excreted by the kidneys. Recently, new urinary and serum biomarkers have gained a place in the diagnosis, classification, and prognosis prediction of AKI. The best treatment for AKI is prevention. Patients with prerenal azotemia should have intravascular volume deficits corrected and cardiac function optimized. Obstructive (postrenal) kidney disease is treated by mechanical relief of the block. The primary management of acute interstitial nephritis is discontinuation of the inciting agent. Renal replacement therapy (RRT) has emerged as a supportive mechanism rather than just as a lifesaving measure. Continuous techniques are preferable in treating critically ill patients, although every modality has its benefits, indications, and contraindications.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Jose J. Zaragoza and Faustino J. Renteria",authors:[{id:"181646",title:"Dr.",name:"Jose",middleName:"Jesus",surname:"Zaragoza",slug:"jose-zaragoza",fullName:"Jose Zaragoza"},{id:"200843",title:"Dr.",name:"Faustino",middleName:null,surname:"Renteria",slug:"faustino-renteria",fullName:"Faustino Renteria"}]}],mostDownloadedChaptersLast30Days:[{id:"55736",title:"Haemodynamic Monitoring in the Intensive Care Unit",slug:"haemodynamic-monitoring-in-the-intensive-care-unit",totalDownloads:3370,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"Monitoring is a cognitive aid that allows clinicians to detect the nature and extent of pathology and helps assessment of response to therapy. The cardiovascular system is the most commonly monitored organ system in the critical care setting. It helps identify the presence and nature of shock and guides response to resuscitation by detection of cardiac rate and rhythm, evaluation of volume state, cardiac contractility and systemic vascular resistance. Newer technologies allow greater assessment of oxygen delivery to vulnerable tissues. We discuss the nature, history, modalities and interpretation of the most commonly available haemodynamic monitoring methods in clinical use currently.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Mainak Majumdar",authors:[{id:"86678",title:"Dr.",name:"Mainak",middleName:null,surname:"Majumdar",slug:"mainak-majumdar",fullName:"Mainak Majumdar"}]},{id:"56744",title:"Endotracheal Intubation in Children: Practice Recommendations, Insights, and Future Directions",slug:"endotracheal-intubation-in-children-practice-recommendations-insights-and-future-directions",totalDownloads:2450,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Management of airway is mandatory in a critically ill child with severe trauma or any other situation that threatens his or her life. It is important, that clinicians who attend critically ill pediatric patients requiring airway management know the rapid sequence intubation (RSI) procedure, identify a patient with difficult airway, know the devices and techniques for the management of difficult airway, and look for receiving a formal training in endotracheal intubation (ETI). Future strategies for teaching and/or training clinicians in pediatric and neonatal ETI should be evaluated through conducting controlled clinical trials to identify which type will be the most effective by considering the less number of attempts and complications.",book:{id:"5970",slug:"bedside-procedures",title:"Bedside Procedures",fullTitle:"Bedside Procedures"},signatures:"Maribel Ibarra-Sarlat, Eduardo Terrones-Vargas, Lizett Romero-\nEspinoza, Graciela Castañeda-Muciño, Alejandro Herrera-Landero\nand Juan Carlos Núñez-Enríquez",authors:[{id:"166303",title:"Dr.",name:"Juan",middleName:"Carlos",surname:"Nuñez-Enriquez",slug:"juan-nunez-enriquez",fullName:"Juan Nuñez-Enriquez"},{id:"206296",title:"Dr.",name:"Eduardo",middleName:null,surname:"Terrones-Vargas",slug:"eduardo-terrones-vargas",fullName:"Eduardo Terrones-Vargas"},{id:"206297",title:"Dr.",name:"Maribel",middleName:null,surname:"Ibarra-Sarlat",slug:"maribel-ibarra-sarlat",fullName:"Maribel Ibarra-Sarlat"},{id:"206298",title:"Dr.",name:"Lizett",middleName:null,surname:"Romero-Espinoza",slug:"lizett-romero-espinoza",fullName:"Lizett Romero-Espinoza"},{id:"206299",title:"Dr.",name:"Alejandro",middleName:null,surname:"Herrera-Landero",slug:"alejandro-herrera-landero",fullName:"Alejandro Herrera-Landero"},{id:"213723",title:"Dr.",name:"Graciela",middleName:null,surname:"Castañeda-Muciño",slug:"graciela-castaneda-mucino",fullName:"Graciela Castañeda-Muciño"}]},{id:"55848",title:"Airway Management in ICU Settings",slug:"airway-management-in-icu-settings",totalDownloads:2864,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"Maintenance of patent airway, adequate ventilation, and pulmonary gas exchange is very important in critically ill patients. Airway management in intensive care patients differs significantly from routine surgical procedures in the operating room. The airway competence in intensive care unit (ICU) should be coping with the rapidly evolving advances in airway management. Therefore, efforts should be focused on the three pillars of airway master: airway providers as intensivists or critical care physicians, equipment, and operational plans. Not all institutions can afford all airway equipment in the market; however, they should make sure that critical care providers have a full access to the available tools and they are comfortable using it. Educational sessions and refresher courses should be tailored to meet the competence level of the ICU providers and equipment availability. Operational plan includes developing institutional airway protocols and implementing difficult airway guidelines. The protocols should consider different staffing models of ICU and make sure all the time at least one member of the team with the highest experience in airway should be always available. The aim of writing this chapter is to enable the intensivist to optimize their use of airway equipment and managing high‐risk patients in ICU.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Nabil Abdelhamid Shallik, Mamdouh Almustafa, Ahmed Zaghw\nand Abbas Moustafa",authors:[{id:"202782",title:"Dr.",name:"Nabil A.",middleName:null,surname:"Shallik",slug:"nabil-a.-shallik",fullName:"Nabil A. Shallik"},{id:"206965",title:"Dr.",name:"Mamdouh",middleName:null,surname:"Almustafa",slug:"mamdouh-almustafa",fullName:"Mamdouh Almustafa"},{id:"206966",title:"Dr.",name:"Ahmed",middleName:null,surname:"Zaghw",slug:"ahmed-zaghw",fullName:"Ahmed Zaghw"},{id:"206967",title:"Dr.",name:"Abbas",middleName:null,surname:"Moustafa",slug:"abbas-moustafa",fullName:"Abbas Moustafa"}]},{id:"56878",title:"Lumbar Puncture of the Newborn",slug:"lumbar-puncture-of-the-newborn",totalDownloads:1461,totalCrossrefCites:1,totalDimensionsCites:3,abstract:"Heinrich Irenäus Quincke was the first person in medical history to perform lumbar puncture (LP). Indications of lumbar puncture include suspected meningitis, suspected subarachnoid hemorrhage, administration of chemotherapeutic agents, instillation of contrast media for imaging of the spinal cord, and the evaluation of various neurologic conditions including normal pressure hydrocephalus and Guillain-Barré syndrome, and the treatment of idiopathic intracranial hypertension. Contraindications of lumbar puncture include findings of increased intracranial pressure, bleeding diathesis, cardiopulmonary instability, soft tissue infection at the puncture site, shock, respiratory insufficiency, and suspected meningococcal septicemia with extensive or spreading purpura. Altered mental status, focal neurologic signs, papilledema, focal seizure, and risk for brain abscess are indications for cranial imaging before performing LP. Lack of local anesthetic use and advancement of the spinal needle with the stylet in place were most prominent risk factors for a traumatic LP. Ultrasound may minimize the number of LP attempts and decrease patient and parent anxiety by easily identifying an insertion site. Infection, spinal hematoma, epidermoid tumor, and cerebral herniation are the main complications of LP. When LP is traumatic, the wisest approach is to assume the patient is having meningitis and start empirical therapy.",book:{id:"5970",slug:"bedside-procedures",title:"Bedside Procedures",fullTitle:"Bedside Procedures"},signatures:"Selim Öncel",authors:[{id:"200133",title:"Associate Prof.",name:"Selim",middleName:null,surname:"Öncel",slug:"selim-oncel",fullName:"Selim Öncel"}]},{id:"55443",title:"Aneurysmal Subarachnoid Hemorrhage",slug:"aneurysmal-subarachnoid-hemorrhage",totalDownloads:2938,totalCrossrefCites:1,totalDimensionsCites:3,abstract:"Aneurysmal subarachnoid hemorrhage (SAH) is a devastating neurological syndrome, which occurs at a rate of 3–25 per 100,000 population. Smoking and hypertension are the most important risk factors of subarachnoid hemorrhage. Rupture of cerebral aneurysm leads to rapid spread of blood into cerebrospinal fluid and subsequently leads to sudden increase of intracranial pressure and severe headache. Subarachnoid hemorrhage is associated with neurological (such as re‐bleeding and vasospasm) and systemic (such as myocardial injury and hyponatremia) complications that are causes of high mortality and morbidity. Although patients with poor‐grade subarachnoid hemorrhage are at higher risk of neurological and systemic complications, the early and aggressive management of this group of patient has decreased overall mortality by 17% in last 40 years. Early aneurysm repair, close monitoring in dedicated neurological intensive care unit, prevention, and aggressive management of medical and neurological complications are the most important strategies to improve outcome.",book:{id:"5756",slug:"intensive-care",title:"Intensive Care",fullTitle:"Intensive Care"},signatures:"Adel E. Ahmed Ganaw, Abdulgafoor M. Tharayil, Ali O. Mohamed\nBel Khair, Saher Tahseen, Jazib Hassan, Mohammad Faisal Abdullah\nMalmstrom and Sohel Mohamed Gamal Ahmed",authors:[{id:"198979",title:"Dr.",name:"Saher",middleName:null,surname:"Tahseen",slug:"saher-tahseen",fullName:"Saher Tahseen"},{id:"199923",title:"Dr.",name:"Adel. E. Ahmad",middleName:null,surname:"Ganaw",slug:"adel.-e.-ahmad-ganaw",fullName:"Adel. E. Ahmad Ganaw"},{id:"200584",title:"Dr.",name:"Abdulgafoor",middleName:null,surname:"Tharayil",slug:"abdulgafoor-tharayil",fullName:"Abdulgafoor Tharayil"},{id:"205193",title:"Dr.",name:"Ali",middleName:"O Mohamed",surname:"Bel Khair",slug:"ali-bel-khair",fullName:"Ali Bel Khair"},{id:"205194",title:"Dr.",name:"Jazib",middleName:null,surname:"Hassan",slug:"jazib-hassan",fullName:"Jazib Hassan"},{id:"205195",title:"Dr.",name:"M. Faisal",middleName:null,surname:"Malmstrom",slug:"m.-faisal-malmstrom",fullName:"M. Faisal Malmstrom"},{id:"205787",title:"Dr.",name:"Sohel Mohamed Gamal",middleName:null,surname:"Ahmed",slug:"sohel-mohamed-gamal-ahmed",fullName:"Sohel Mohamed Gamal Ahmed"}]}],onlineFirstChaptersFilter:{topicId:"993",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:332,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:143,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:124,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:23,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:12,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:"2753-6580",scope:"\r\n\tSustainable approaches to health and wellbeing in our COVID 19 recovery needs to focus on ecological approaches that prioritize our relationships with each other, and include engagement with nature, the arts and our heritage. This will ensure that we discover ways to live in our world that allows us and other beings to flourish. We can no longer rely on medicalized approaches to health that wait for people to become ill before attempting to treat them. We need to live in harmony with nature and rediscover the beauty and balance in our everyday lives and surroundings, which contribute to our well-being and that of all other creatures on the planet. This topic will provide insights and knowledge into how to achieve this change in health care that is based on ecologically sustainable practices.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/92.jpg",hasOnlineFirst:!1,hasPublishedBooks:!1,annualVolume:11976,editor:{id:"348225",title:"Prof.",name:"Ann",middleName:null,surname:"Hemingway",slug:"ann-hemingway",fullName:"Ann Hemingway",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035LZFoQAO/Profile_Picture_2022-04-11T14:55:40.jpg",biography:"Professor Hemingway is a public health researcher, Bournemouth University, undertaking international and UK research focused on reducing inequalities in health outcomes for marginalised and excluded populations and more recently focused on equine assisted interventions.",institutionString:null,institution:{name:"Bournemouth University",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null,series:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:"2753-6580"},editorialBoard:[{id:"169536",title:"Dr.",name:"David",middleName:null,surname:"Claborn",slug:"david-claborn",fullName:"David Claborn",profilePictureURL:"https://mts.intechopen.com/storage/users/169536/images/system/169536.jpeg",institutionString:null,institution:{name:"Missouri State University",institutionURL:null,country:{name:"United States of America"}}},{id:"248594",title:"Ph.D.",name:"Jasneth",middleName:null,surname:"Mullings",slug:"jasneth-mullings",fullName:"Jasneth Mullings",profilePictureURL:"https://mts.intechopen.com/storage/users/248594/images/system/248594.jpeg",institutionString:"The University Of The West Indies - Mona Campus, Jamaica",institution:null},{id:"331299",title:"Prof.",name:"Pei-Shan",middleName:null,surname:"Liao",slug:"pei-shan-liao",fullName:"Pei-Shan Liao",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000032Fh2FQAS/Profile_Picture_2022-03-18T09:39:41.jpg",institutionString:"Research Center for Humanities and Social Sciences, Academia Sinica, Taiwan",institution:null}]},onlineFirstChapters:{paginationCount:7,paginationItems:[{id:"83087",title:"Role of Cellular Responses in Periodontal Tissue Destruction",doi:"10.5772/intechopen.106645",signatures:"Nam Cong-Nhat Huynh",slug:"role-of-cellular-responses-in-periodontal-tissue-destruction",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Periodontology - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11566.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82654",title:"Atraumatic Restorative Treatment: More than a Minimally Invasive Approach?",doi:"10.5772/intechopen.105623",signatures:"Manal A. Ablal",slug:"atraumatic-restorative-treatment-more-than-a-minimally-invasive-approach",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82735",title:"The Influence of Salivary pH on the Prevalence of Dental Caries",doi:"10.5772/intechopen.106154",signatures:"Laura-Cristina Rusu, Alexandra Roi, Ciprian-Ioan Roi, Codruta Victoria Tigmeanu and Lavinia Cosmina Ardelean",slug:"the-influence-of-salivary-ph-on-the-prevalence-of-dental-caries",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82357",title:"Caries Management Aided by Fluorescence-Based Devices",doi:"10.5772/intechopen.105567",signatures:"Atena Galuscan, Daniela Jumanca and Aurora Doris Fratila",slug:"caries-management-aided-by-fluorescence-based-devices",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"81894",title:"Diet and Nutrition and Their Relationship with Early Childhood Dental Caries",doi:"10.5772/intechopen.105123",signatures:"Luanna Gonçalves Ferreira, Giuliana de Campos Chaves Lamarque and Francisco Wanderley Garcia Paula-Silva",slug:"diet-and-nutrition-and-their-relationship-with-early-childhood-dental-caries",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"78064",title:"The Salivary Secretome",doi:"10.5772/intechopen.98278",signatures:"Luís Perpétuo, Rita Ferreira, Sofia Guedes, Francisco Amado and Rui Vitorino",slug:"the-salivary-secretome",totalDownloads:108,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Periodontology - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11566.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"65334",title:"Introductory Chapter: Some Important Aspects of Root Canal Treatment",doi:"10.5772/intechopen.83653",signatures:"Ana Luiza de Carvalho Felippini",slug:"introductory-chapter-some-important-aspects-of-root-canal-treatment",totalDownloads:850,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ana Luiza",surname:"De Carvalho Felippini"}],book:{title:"Root Canal",coverURL:"https://cdn.intechopen.com/books/images_new/7133.jpg",subseries:{id:"1",title:"Oral Health"}}}]},publishedBooks:{paginationCount:5,paginationItems:[{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",slug:"rabies-virus-at-the-beginning-of-21st-century",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Sergey Tkachev",hash:"49cce3f548da548c718c865feb343509",volumeInSeries:9,fullTitle:"Rabies Virus at the Beginning of 21st Century",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev",profilePictureURL:"https://mts.intechopen.com/storage/users/61139/images/system/61139.png",institutionString:"Russian Academy of Sciences",institution:{name:"Russian Academy of Sciences",institutionURL:null,country:{name:"Russia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10497",title:"Canine Genetics, Health and Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10497.jpg",slug:"canine-genetics-health-and-medicine",publishedDate:"June 2nd 2021",editedByType:"Edited by",bookSignature:"Catrin Rutland",hash:"b91512e31ce34032e560362e6cbccc1c",volumeInSeries:7,fullTitle:"Canine Genetics, Health and Medicine",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9081",title:"Equine Science",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9081.jpg",slug:"equine-science",publishedDate:"September 23rd 2020",editedByType:"Edited by",bookSignature:"Catrin Rutland and Albert Rizvanov",hash:"ac415ef2f5450fa80fdb9cf6cf32cd2d",volumeInSeries:5,fullTitle:"Equine Science",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8524",title:"Lactation in Farm Animals",subtitle:"Biology, Physiological Basis, Nutritional Requirements, and Modelization",coverURL:"https://cdn.intechopen.com/books/images_new/8524.jpg",slug:"lactation-in-farm-animals-biology-physiological-basis-nutritional-requirements-and-modelization",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Naceur M'Hamdi",hash:"2aa2a9a0ec13040bbf0455e34625504e",volumeInSeries:3,fullTitle:"Lactation in Farm Animals - Biology, Physiological Basis, Nutritional Requirements, and Modelization",editors:[{id:"73376",title:"Dr.",name:"Naceur",middleName:null,surname:"M'Hamdi",slug:"naceur-m'hamdi",fullName:"Naceur M'Hamdi",profilePictureURL:"https://mts.intechopen.com/storage/users/73376/images/system/73376.jpg",institutionString:null,institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7144",title:"Veterinary Anatomy and Physiology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7144.jpg",slug:"veterinary-anatomy-and-physiology",publishedDate:"March 13th 2019",editedByType:"Edited by",bookSignature:"Catrin Sian Rutland and Valentina Kubale",hash:"75cdacb570e0e6d15a5f6e69640d87c9",volumeInSeries:2,fullTitle:"Veterinary Anatomy and Physiology",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:330,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:10,numberOfPublishedChapters:141,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:124,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:22,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:12,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"August 14th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:3,numberOfPublishedChapters:108,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},subseries:[{id:"7",title:"Bioinformatics and Medical Informatics",keywords:"Biomedical Data, Drug Discovery, Clinical Diagnostics, Decoding Human Genome, AI in Personalized Medicine, Disease-prevention Strategies, Big Data Analysis in Medicine",scope:"Bioinformatics aims to help understand the functioning of the mechanisms of living organisms through the construction and use of quantitative tools. The applications of this research cover many related fields, such as biotechnology and medicine, where, for example, Bioinformatics contributes to faster drug design, DNA analysis in forensics, and DNA sequence analysis in the field of personalized medicine. Personalized medicine is a type of medical care in which treatment is customized individually for each patient. Personalized medicine enables more effective therapy, reduces the costs of therapy and clinical trials, and also minimizes the risk of side effects. Nevertheless, advances in personalized medicine would not have been possible without bioinformatics, which can analyze the human genome and other vast amounts of biomedical data, especially in genetics. The rapid growth of information technology enabled the development of new tools to decode human genomes, large-scale studies of genetic variations and medical informatics. The considerable development of technology, including the computing power of computers, is also conducive to the development of bioinformatics, including personalized medicine. In an era of rapidly growing data volumes and ever lower costs of generating, storing and computing data, personalized medicine holds great promises. Modern computational methods used as bioinformatics tools can integrate multi-scale, multi-modal and longitudinal patient data to create even more effective and safer therapy and disease prevention methods. Main aspects of the topic are: Applying bioinformatics in drug discovery and development; Bioinformatics in clinical diagnostics (genetic variants that act as markers for a condition or a disease); Blockchain and Artificial Intelligence/Machine Learning in personalized medicine; Customize disease-prevention strategies in personalized medicine; Big data analysis in personalized medicine; Translating stratification algorithms into clinical practice of personalized medicine.",annualVolume:11403,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"5886",title:"Dr.",name:"Alexandros",middleName:"T.",surname:"Tzallas",fullName:"Alexandros Tzallas",profilePictureURL:"https://mts.intechopen.com/storage/users/5886/images/system/5886.png",institutionString:"University of Ioannina, Greece & Imperial College London",institution:{name:"University of Ioannina",institutionURL:null,country:{name:"Greece"}}},{id:"257388",title:"Distinguished Prof.",name:"Lulu",middleName:null,surname:"Wang",fullName:"Lulu Wang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRX6kQAG/Profile_Picture_1630329584194",institutionString:"Shenzhen Technology University",institution:{name:"Shenzhen Technology University",institutionURL:null,country:{name:"China"}}},{id:"225387",title:"Prof.",name:"Reda R.",middleName:"R.",surname:"Gharieb",fullName:"Reda R. Gharieb",profilePictureURL:"https://mts.intechopen.com/storage/users/225387/images/system/225387.jpg",institutionString:"Assiut University",institution:{name:"Assiut University",institutionURL:null,country:{name:"Egypt"}}}]},{id:"8",title:"Bioinspired Technology and Biomechanics",keywords:"Bioinspired Systems, Biomechanics, Assistive Technology, Rehabilitation",scope:'Bioinspired technologies take advantage of understanding the actual biological system to provide solutions to problems in several areas. Recently, bioinspired systems have been successfully employing biomechanics to develop and improve assistive technology and rehabilitation devices. The research topic "Bioinspired Technology and Biomechanics" welcomes studies reporting recent advances in bioinspired technologies that contribute to individuals\' health, inclusion, and rehabilitation. Possible contributions can address (but are not limited to) the following research topics: Bioinspired design and control of exoskeletons, orthoses, and prostheses; Experimental evaluation of the effect of assistive devices (e.g., influence on gait, balance, and neuromuscular system); Bioinspired technologies for rehabilitation, including clinical studies reporting evaluations; Application of neuromuscular and biomechanical models to the development of bioinspired technology.',annualVolume:11404,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"49517",title:"Prof.",name:"Hitoshi",middleName:null,surname:"Tsunashima",fullName:"Hitoshi Tsunashima",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTP4QAO/Profile_Picture_1625819726528",institutionString:null,institution:{name:"Nihon University",institutionURL:null,country:{name:"Japan"}}},{id:"425354",title:"Dr.",name:"Marcus",middleName:"Fraga",surname:"Vieira",fullName:"Marcus Vieira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003BJSgIQAX/Profile_Picture_1627904687309",institutionString:null,institution:{name:"Universidade Federal de Goiás",institutionURL:null,country:{name:"Brazil"}}},{id:"196746",title:"Dr.",name:"Ramana",middleName:null,surname:"Vinjamuri",fullName:"Ramana Vinjamuri",profilePictureURL:"https://mts.intechopen.com/storage/users/196746/images/system/196746.jpeg",institutionString:"University of Maryland, Baltimore County",institution:{name:"University of Maryland, Baltimore County",institutionURL:null,country:{name:"United States of America"}}}]},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",annualVolume:11405,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/70312",hash:"",query:{},params:{id:"70312"},fullPath:"/chapters/70312",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()